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CHAPTER 1  INTRODUCTION 
 
1.1 Introduction to the Problem 
Over the past two decades, there have been dramatic changes in the US 
health plan system. Managed care has experienced an explosive growth. In 1985, 
less than 8% of insured workers were covered by an HMO, and PPOs had just come 
into existence. By 2002, however, nearly 95% of the Americans have some form of 
managed care (Morrisey, Jensen, and Gabel, 2003).  
In contrast to traditional fee-for-service (FFS) insurance, managed care 
contracts with some selected health care providers through negotiating price 
reductions. Managed care organizations also often employ a variety of “incentive 
payment” schemes, such as capitation and “gatekeeper” to shift onto the provider 
some of the risk if the enrollee uses large amounts of health care.  
The underlying intentions of these schemes are to manage or control costs so 
that the care delivered is medically necessary and appropriate for the patient’s 
condition. However, the use of price discounts, capitation, and “gatekeeper” by 
managers gives providers incentives to reduce costs, possibly by limiting access to 
health care or lowering health care services. These incentives raise quality concerns 
regarding health care services. Over the last two decades, numerous studies have 
sought to evaluate quality of care effects of managed care plans as compared with 
traditional FFS plans. Although many studies showed that managed care plans 
provided comparable quality in providing health care services (Miller and Luft, 2002, 
1997, 1994), others did show lower quality of care in HMOs serving Medicare seniors, 
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stroke patients, and frail adults (Miller and Luft, 2002, 1997; Experton, Ozminkowski, 
Pearlman, Li, and Thompson, 1999; Smith, Shahar, McGovern, Kane, Doliszny, 
Arnett, and Luepker, 1999). One of the important reasons for this discrepancy is due 
to the different population subgroups used in these studies. This suggests that further 
research is needed for other high-risk patients, such as those with diabetes, because 
of their costly and specific medical needs.   
Diabetes is one of the most prevalent diseases in the United States. According 
to Centers for Disease Control and Prevention (CDC), in 2008, 24 million people had 
diabetes, with a percentage of 8. Every year, diabetes alone costs $132 billion in the 
United States (NDIC), with approximately 16% of all hospital expenditures for people 
with diabetes (WHO 2010). 
Diabetes is among the most common and costly chronic diseases, but it is 
also among the most preventable and treatable diseases. This means there is a 
potential room to maintain or improve health for this cohort of people by providing 
sufficient quantity and quality of health care. As an alternative to traditional FFS plans, 
managed care plans play an extremely important role in providing such sufficient 
health care services to these people. Therefore, it is important to understand quality 
of care effect of managed care on patients with diabetes.   
1.2 Statement of Purpose 
Access to, satisfaction with, and utilization of care, including diabetes care, are 
key measures to evaluate the quality of health care enrollees receive. Health status, 
however, is the outcome. In an effort to evaluate and improve the existing health care 
system, this study will examine the effect of managed care plans, as compared to 
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traditional FFS plans, on patients with diabetes in terms of the above mentioned 
quality of care measures, as well as health outcome.  
1.3 Aims and Objectives of the Study 
The specific aims of the study and the expected contributions are as follows: 
• Focus on patients with diabetes. Despite the population size (eight 
percent, with a foreseeable increase), patients with diabetes merit more attention. 
Knowing better about the effect of managed care plans on diabetes subgroup is of 
great urgency and far-reaching importance to the existing health care system. 
• Separate HMOs from other managed care forms to compare with 
traditional FFSs. Most previous studies have compared HMOs with FFS or combined 
HMOs with other managed care forms to make comparisons. As HMOs and other 
forms of managed care deliver the payment in different ways, separating HMOs from 
other managed care would provide more precise information to the public and policy 
makers.  
• Evaluate the quality of care effect of managed care from multiple 
dimensions. Most previous studies evaluate quality of care effect of managed care 
from a single dimension or limited dimensions. To provide more comprehensive 
results, we try to use multiple measurements, such as diabetes care, health care 
access, satisfaction, utilization, as well as health outcome, to evaluate the quality of 
care. 
• Use up-to-date and national representative data. We are going to use 
the data from Medical Expenditure Panel (MEP). MEPS provides the most complete 
source and up-to-date of data, a source that oversamples Blacks, Hispanics, and 
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diabetics. When weighted, it provides nationally representative estimates of health 
care access, satisfaction, utilization, quality, and insurance coverage for the U.S 
civilian, noninstitutionalized population. Moreover, MEPS HC (Household 
Components) collects detailed information for each person in the household on the 
following: demographic characteristics, health conditions, health status, income, and 
employment, etc, which provides completely ready data for our analysis.  
1.4 Rationale 
• Focus on patients with diabetes. Diabetes is common and growing. As 
mentioned earlier, diabetes is among the most prevalent chronic (lifetime) diseases in 
the United States. By 2008, 24 million people have diabetes, a high percentage of 
8%. Diabetes is becoming more common as more and more people become 
overweight and obese (Science Daily, 2009). According to Centers for Disease 
Control and Prevention (CDC) reports, if current trends continue, 1 in 3 Americans 
will develop diabetes sometime in their lifetime. Moreover, since diabetes prevalence 
increases with age (Wilson, Anderson, and Kannel, 1986; Halter, 1995), diabetes 
cases will no doubt grow substantially as the baby boomers age into the near elderly 
or elderly. The World Health Organization (WHO) projected a number of 30.3 million 
diabetes cases by the year of 2030 in the U.S. 
Diabetes is deadly and disabling.  Each year approximately 25 per 100,000 
population died from diabetes in the US. As the No.6 leading cause of death, 
diabetes is the only major disease with a death rate that is still rising (The New York 
Times, 2006). Risk of death for diabetics is twice that of those without diabetes, and 
those with diabetes will lose, on average, 10–15 years of life. In addition, diabetes is 
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the leading cause of new cases of blindness, kidney failure, and non-traumatic lower-
extremity conditions (CDC 2003). Diabetes and its treatments can cause many other 
complications, such as cardiovascular disease, diabetic hyperglycemic crises, and 
visual impairment. People with diabetes have at least twice the risk of heart disease 
or stroke as other people (NDIC 2005).  
Diabetes is costly. Research showed that average medical expenditures 
among people with diagnosed diabetes were 2.3 times higher than what 
expenditures would be in the absence of diabetes (NDIC 2005; Rubin, Altman, and 
Mendelson, 1992; Laditka, Mastanduno, and Laditka, 2001). The National Diabetes 
Information Clearinghouse (NDIC) estimates that diabetes costs $132 billion in the 
United States alone every year. In 2007, the total cost of diabetes was $174 billion, 
with direct medical costs of $116 billion and indirect costs (related to disability, work 
loss, premature death) of $58 billion. A recent analysis of health care expenditure 
from the WHO showed that 16% of hospital expenditure was for people with diabetes 
(WHO 2010).  
No doubt, the foreseeable prevalence of diabetes and its unpleasant 
complications will pose greater challenges to the existing health care delivery system. 
On one hand, the continuous rise in the incidence of diabetes and its complications 
will definitely increase healthcare expense. Cutting health care costs and reducing 
the growth of health care spending are certainly among the primary goals of health 
care reform. On the other hand, however, producing better health results for patients 
is another important goal. Health is a critical indicator of quality life for patients 
themselves, as well as their relatives and friends.  
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Unfortunately, literature on quality of care effect of managed care for patients 
with diabetes is sparse. The existing studies are far from sufficient to address the all-
around multi-effects of managed care on patients with diabetes.  
• Separate HMOs from other managed care forms to compare with 
traditional FFSs. Managed care plans have at least three basic types, ranging from 
more restrictive to less restrictive: (i) Health Maintenance Organizations (HMOs), (ii) 
Preferred Provider Organizations (PPOs), and (iii) Point of Service (POS) plans. To 
some extent, there are similarities between these different types of managed care 
plans. All managed care plans involve an arrangement between the insurer and a 
selected network of health care providers (doctors, hospitals, etc.), and encourages 
policyholders to use the providers in that network. However, there are important 
differences between them as well (Agencyinfo).  
HMO was the original managed-care plan and is typically the most restrictive 
type. In practice, each member is assigned a “gatekeeper”, a primary care physician 
(PCP) who is responsible for the overall care of members assigned to him or her. 
Specialty services and non-emergency hospital admissions require a specific referral 
or pre-authorization from the PCP. Usually, services are not covered if the service 
provider is from outside of the network, unless it is an emergency situation as defined 
by the HMO. HMOs provide medical treatment on a prepaid basis, which means that 
HMO members would pay a fixed monthly fee, regardless of how much medical care 
is needed in a given month. In return for this fee, most HMOs provide a wide variety 
of medical services, from office visits to hospitalization and surgery. The enrollees 
only need co-pay for every visit.  
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PPO, the most common type of managed-care plan, is actually a group of 
doctors and/or hospitals that provides medical service only to a specific group or 
association. Unlike an HMO plan, which has a copayment cost share feature, a PPO 
generally does not have co-pay but offers a deductible and a coinsurance feature 
instead. The deductible represents the first dollar of coverage and is paid by the 
patient. After the deductible is met, the coinsurance portion applies. Generally, PPO 
Plans offer significantly lower deductibles and co-insurance rates compared with 
conventional plans if the patient uses physicians and hospitals that are part of the 
PPO's network of providers. PPOs also allow enrollees to receive services from 
providers outside the network--but at a higher price.  
POS plan is a type of managed healthcare system that combines 
characteristics of the HMO and the PPO. Like an HMO, the enrollees pay no 
deductible and usually only a minimal co-payment when they use a healthcare 
provider within the network. A PCP is required to be responsible for all referrals within 
the POS network. However, if the healthcare was performed from outside of the 
network, POS coverage functions more like a PPO. A deductible (around $300 for an 
individual or $600 for a family) and a co-payment will be then applied.  
Thus, managed care plans, such as HMOs, PPOs, and POSs, differ in 
important characteristics and performance, as do provider organizations, including in 
how to pay physician organizations, how physician organizations pay physicians, and 
how well the clinical care is organized. Putting all plans together or averages of their 
performance will give misleading results. Therefore, if possible, it is necessary to 
separate HMOs, PPOs and POSs in making a comparison with traditional FFS plans. 
8 
 
Due to the data constraint, our study will just separate HMOs from other managed 
care forms to compare with traditional FFSs.  
• Evaluate the quality of care effect of managed care from multiple 
dimensions.  Existing research on subgroups with chronic diseases, such as heart 
diseases and cancers, examined various dimensions of health care provision, such 
as access to, satisfaction with, and healthcare use. More specifically, for patients with 
heart diseases, these studies compared managed care plans and fee-for-service 
plans for quality of care in terms of hospital care, mortality rate, use of helpful 
medications and surgery, length of stay (LOS), etc (Erikson, Torchiana, Schneider, 
Newburger, and Hannan, 2000; Erickson, Wise, Cook, Beiser, and Newburger, 2000; 
Guadagnoli, Landrum, Peterson, Gahart, Ryan, and NcNeil, 2000; Bundorf, 
Schulman, Stafford, Gaskin, Jollis, and Escarce, 2004). For patients with cancer, 
most of the studies focused on prevention, early diagnosis, and treatments effect 
(Lee-Feldstein, Feldstein, Buchmueller, and Katterhagen, 2000; Roetzheim, Pal, 
Gonzalez, Ferrante, Van Durme, and Krischer, 2000). Results from these studies 
cannot be generalized to patients with diabetes as they need specific medical care, 
especially diabetes care. However, they inspire this study to try from multiple 
dimensions to investigate quality of care of managed care plans on patients with 
diabetes. Besides, most of the existing studies on the diabetes subgroup only 
examined from a single or very limited aspect(s) of quality of care (Retchin and 
Preston, 1991; Greenfield, Rogers, Mangotich, Carney, and Tarlov, 1995; Brown, 
Jiang, and Fong, 2005). Multiple aspects of quality of care effects are needed to 
provide more comprehensive results. 
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• Use up-to-date and national representative data. Most of the studies 
selected data which cannot be generalized to the national size of population. For 
example, Retchin et al. (1991) chose only 158 elderly diabetics enrolled in HMOs and 
134 similar diabetics in FFS settings to make the comparison. Lee, Meredith, Whitcup, 
Spritzer, and Hays (1998) used only 522 individuals with diabetes enrolled in the 
Medical Outcomes Study (MOS). Moreover, some studies became outdated as they 
used very old data and were published more than ten years ago. Managed care has 
changed dramatically over the years (Latif 2000). There is a paucity of current data 
and current report to inform the public and health policymakers 
Based on these considerations, updating is urgently needed. This study, 
therefore, by using most recently published national data, will provide some empirical 
evidence about quality of care effect of managed care plans on the subgroup of the 
diabetics. Hopefully, this study can provide useful information for the public, insurers, 
as well as policymakers in an effort to establish a more efficient and effective health 
care delivery system.  
1.5 Description of Dissertation Organization  
The rest of this dissertation is organized as follows. In Chapter two, we review 
the literature about quality of care effect of managed care as compared to traditional 
FFS plans on patients with diabetes. In Chapter three, we investigate quality of care 
effect of managed care in terms of access to, satisfaction with, and use of health care 
as compared to traditional FFS plans.  Chapter four examines quality of care effect of 
managed care in terms of health outcome as compared to traditional FFS plans. 
These two chapters fit closely together to support each other. However, each of them 
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is intended as a stand-alone study that addresses a specific question. They use 
different methods and have been structured independently. The empirical results and 
discussions for each model are presented separately by different chapters. Finally, 
Chapter five presents conclusions and future work.   
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CHAPTER TWO  LITERATURE REVIEW 
 
2.1 Introduction  
This chapter gives an overview of the literature on the quality of care effects of 
managed care plans as compared to traditional fee for service plans.  In particular, 
this review will focus on a few existing studies which made this comparison among 
patients with diabetes.  
2.2 Historical Background/Overview  
Much attention has been paid to health care quality effects of managed care 
as more and more people switched health plan from traditional fee-for-service to 
managed care. As early as in 1978, Luft tried to compare HMOs with FFSs and found 
that HMO enrollees had lower hospitalization rates, although no clear evidence 
showed that these lower rates were attributable to reductions in discretionary or 
“unnecessary” categories. Later in 1984, Arnould and colleagues confirmed that 
length of stay was not significantly different between HMO and FFS patients. 
However, they found that the use of surgeon visits, as well as lab charges, per 
patient was lower for HMO users.  
Another frequently cited early study, the RAND Health Insurance Experiment 
(Manning, Leibowitz, Goldberg, Rogers and Newhouse, 1984) compared the 
performance of a staff HMO plan (1149 persons), Group Health Cooperative in 
Seattle, Wash, with indemnity plans (431 persons) using 1976 to 1980 data.  
Meanwhile, 733 prior enrollees of the Cooperative were studied as a control group. 
The authors found that the rate of hospital admissions in both groups at the 
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Cooperative was about 40 percent less than in the fee-for-service group, although 
ambulatory-visit rates were similar, and the number of preventive visits was higher in 
the prepaid groups.  
Later on in the nineties, a large number of relevant studies were performed as 
managed care experienced an explosive expansion. The most comprehensive 
collections were the literature reviews conducted by Miller and Luft in 1994, 1997, 
and 2002, respectively.  
In 1994, Miller and Luft reviewed fifty-four studies and compared the health 
care utilization, expenditure, quality of care, and satisfaction of enrollees in managed 
care and indemnity plans. Studies selected met the following criteria: data from 1980 
forward, private insurance or Medicare enrollees, a comparison group, a reasonable 
attempt at statistical adjustment for noncomparable managed care and indemnity 
plan enrollees, and peer-reviewed findings. In the analysis, they found that compared 
to indemnity plans, HMO plans had somewhat lower hospital admission rates, 1% to 
20% shorter hospital length of stay, the same or more physician office visits per 
enrollee, less use of expensive procedures and tests, greater use of preventive 
services, mixed results on outcomes, and somewhat lower enrollee satisfaction with 
services but higher satisfaction with costs.  
In 1997, they assessed thirty-seven studies on managed care performance 
from the last quarter of 1993 through the last half of 1996/early 1997. Quality of care 
evidence from fifteen studies showed an equal number of significantly better and 
worse HMO results, compared with non-HMO plans: five observations from four 
studies showed significantly better HMO results, whereas five observations from five 
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studies showed significantly worse HMO results, and one important Medical 
Outcomes Study observation on chronically ill elderly enrollees showed significantly 
worse quality of care for physical health and significantly worse quality of care for 
mental health. In several instances, Medicare HMO enrollees with chronic conditions 
showed worse quality of care. Evidence comparing hospital and physician resource 
use showed no clear pattern, whereas evidence on more costly procedures or home 
health care spending showed lower use in HMO enrollees. For the overall 
satisfaction, it was lower among managed care enrollees. However, HMO/managed 
care enrollees had higher levels of satisfaction with financial aspects than did fee-for-
service. 
In 2002, they updated their analysis of the HMO plan performance on various 
dimensions from peer-reviewed literature published from 1997 to mid-2001. Results 
from seventy-nine studies suggested that both types of plans provide roughly 
comparable quality of care, while HMOs lowered use of hospital and other expensive 
resources somewhat. At the same time, HMO enrollees reported worse results on 
many resources of access to care and lower levels of satisfaction, compared with 
non-HMO enrollees.  
Another recent body of research includes, but is not limited to the following.  
Newacheck, Hung, Marchi, Hughes, Pitter and Stoddard (2001) examined the impact 
of managed care on children's access, satisfaction, use, and quality of care, 
suggesting that there were no statistically significant differences in these indicators 
for children enrolled in managed care and traditional health plans. Barton, Dayhoff, 
Soumerai, Rosenbach, and Fletcher (2001) claimed that the access to care for 
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elderly Medicare beneficiaries in one large managed care organization in New 
England was as good as or better than that in FFS care in the same geographic area. 
Safran, Wilson, Rogers, Montgomery, and Chang (2002) compared the primary care 
received by seniors in Medicare HMOs with that of seniors in the traditional FFS 
Medicare program. They found that for 9 of 11 indicators, performance favored 
traditional FFS Medicare over HMOs, while financial access favored HMOs, and 
preventive counseling did not differ by systems.  
Paramore and Elixhauser (2002) evaluated the occurrence of preventable 
hospitalizations among managed care (MCO) versus fee for service (FFS) 
populations to compare access to and appropriateness of preventive, primary, and 
surgical health care services. They suggested that rates of preventable 
hospitalizations for two of the conditions evaluated (perforated appendix and 
diabetes complications) were lower for MCO enrollees. For two additional indicators 
(immunization preventable pneumonia and low birth weight), MCO rates were no 
different from FFS rates, while results for pediatric asthma were inconclusive. Lee-
Feldstein, Feldstein, and Buchmueller (2002) inquired whether HMOs emphasize 
early diagnosis of colorectal cancer to a greater extent than FFS plans and how this 
pertains to survival. They found that the likelihood of early stage colorectal cancer 
was greater for Medicare patients in nongroup model HMOs or having private FFS 
supplements than for those in group model HMOs, Medicare/Medicaid, or Medicare 
alone. All-cause and colorectal cancer mortality did not differ significantly among 
Medicare patients with group model HMO, nongroup model HMO, and private FFS 
supplements.  Beatty, Hagglund, Neri, Dhont, Clark, and Hilton (2003) examined 
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patterns of access to a variety of specific healthcare services among people with 
chronic or disabling conditions. Results indicated that respondents covered by fee-
for-service health plans were more likely than those covered by managed care 
organizations to receive needed services from specialists.  
Therefore, great efforts have been made from different aspects of quality of 
care to evaluate the effect of managed care plans as compared to traditional FFS 
plans. Researchers have even tried to examine different population subgroups, both 
on general, special, and specific-disease populations, aiming to provide 
comprehensive comparative information across diverse healthcare delivery systems. 
Among the above-mentioned studies, at least eighteen papers evaluated quality of 
care effect of managed care plans on patients with heart diseases, as it is the No. 1 
killer in the U.S. More than twenty studies were focusing on different kinds of cancers, 
the second leading cause of death. Other studies examined on subgroups with stroke, 
hypertension, arthritis, mental health, and etc. Surprisingly, research about the quality 
of care effect of managed care plans, on patients with diabetes, has been sparse.  As 
the sixth largest killer of all children and adults in the U.S (CDC, 2010), and the only 
major disease with a death rate that is still rising, diabetes has attracted less attention 
than it should be from the perspective of quality of care in different health plans. 
2.3 Review of Literature Summary on Diabetes 
Among the few studies related to diabetes, Retchin and Preston (1991) 
evaluated the quality of care in HMOs for elderly diabetics in terms of many different 
indicators of diabetic care. Samples of both HMO and FFS Medicare patients were 
drawn from 8 of 27 HMOs in the National Medicare Competition Evaluation during the 
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years of 1983 to 1986. The authors used Student’s t test to make inferential 
comparisons for differences in demographics or length of time followed up in the 
practice between HMO and FFS settings. However, for comparisons regarding 
evaluations, laboratory testing, and management decisions, the Cochran-Mantel-
Haenszel statistic was used to control for differences. Results showed that influenza 
vaccinations were unfavorable to HMOs; however, indicators of urinalyses, 
funduscopic examinations or referrals to ophthalmologists within 2 years of diagnosis, 
poor diabetic control to be referred to an ophthalmologist for eye evaluations, and 
tolbutamide taking were favorable to HMOs. No other indicators, such as peripheral 
vascular examinations (as a means of evaluating vascular complications of diabetes), 
blood pressure checks, annual renal function evaluations (creatinine or serum urea 
nitrogen) and electrocardiograms within 6 months, etc (about 12 indicators as shown 
on the bottom table), showed significantly different in both settings. The authors 
concluded that most aspects of the quality of diabetic care were similar in HMO and 
FFS settings and were unaffected by the effort at cost containment.  
Another study by Greenfield, Rogers, Mangotich, Carney, and Tarloy (1995) 
also examined diabetes care for Non-Insulin-Dependent Diabetes Mellitus (NIDDM). 
Samples were chosen from three types of health plans: 259 patients from staff-model 
HMOs; 61 from independent practice association (IPA), including prepaid patients of 
Multi-Specialty Groups (MSGs) and solo or small single-specialty practices; 212 
patients from FFS, including MSGs and solo or small single-specialty groups. Mean 
difference and confidence intervals were computed for contrasts between HMO and 
FFS systems and between IPA and FFS systems by using an analysis of variance 
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model. Most of the indicators of quality of care including mean glycosylated 
hemoglobin level, mean scores for vibration sense, visual acuity, albumin excretion 
rate, and blood pressure, etc (about 12 indicators as shown on the bottom table ),  
were not statistically significant among the three systems, except significantly fewer 
HMO patients than FFS or IPA patients were treated by subspecialists.  
Coffey, Moscovice, Finch, Christianson, and Lurie (1995) measured the quality 
of care for diabetic elderly Medcaid beneficiaries in terms of drug and non-drug 
therapy, monitoring, and access to medications. Ninety-six diabetics aged 65 years 
or over enrolled in the Medicaid Demonstration Project in Hennepin County, 
Minnesota, were randomly assigned in one of seven managed care health plans or in 
an FFS plan. Student’s t-tests and chi-square techniques were used to compare the 
managed care and FFS groups. The only difference finding in this study was that, 
more patients in the FFS group were using human insulin after 1 year, although this 
may imply that managed care plans contain costs by restricting clients’ access to this 
expensive drug. No other difference were found in terms of access to medication, 
referring to another practitioner for help with weight loss if they were overweighted, 
diet counseling, or a smoking cessation program, etc (about 6 indicators as shown at 
the bottom table).   
Ware, Bayliss, Rogers, Kosinski, and Tarloy (1996) compared physical and 
mental health outcomes (measured over a 4-year period) of chronically ill adults 
including patients with non-insulin-dependent diabetes mellitus (NIDDM) under HMO 
and FFS systems. 2235 patients (18-97 years of age) from the Medical Outcomes 
Study with more than 1 of the 5 conditions, such as hypertension, NIDDM, acute 
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myocardial infarction, congestive heart failure, and depressive disorder, sampled 
from HMO and FFS systems in 1986 and followed up through 1990. Physical and 
mental health scales were constructed from the MOS 36-Item Short-Form Health 
Survey. The authors used multinomial logistic methods to compare categorical 
changes (better, same, worse) in physical and mental health across HMO and FFS 
systems for the total sample and for the subgroups. Then they used formal statistical 
tests to determine whether conclusions about differences between systems were the 
same across subgroups with different ages, poverty status, Medicaid coverage, and 
initial health.  
In summary, they stated that on average, physical health declined and mental 
health remained stable during the 4-year follow-up period, with physical health 
declined larger for the elderly than for the nonelderly. Physical and mental health 
outcomes did not differ for the average patients, however, they did differ for 
subgroups of the population differing in age and poverty status. In detail, for elderly 
patients treated under Medicare, declines in physical health were more common in 
HMOs than in FFS plans. The average changes in mental health for elderly and 
nonelderly patients did not favor one system over the other. However, analyses of 
mental health change categories for elderly patients favored HMOs over FFS. This 
reason was that in one site (Boston), mental health outcomes were better for elderly 
patients in HMOs relative to FFS, but not in two other sites. For patients differing in 
poverty status, opposite patterns of physical health and for mental health outcomes 
were observed across systems; outcomes favored FFS over HMOs for the poverty 
group and favored HMOs over FFS for the nonpoverty group. 
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Lee, Meredith, Whitcup, Spritzer, and Hays (1998) assessed the health care 
delivery system in terms of self-reported utilization of ophthalmic services. 522 
individuals with diabetes in the Medical Outcomes Study (MOS) were measured. 
Logistic regression results showed that the use of ophthalmic services in the 
preceding six months was not significantly associated with  patient demographics, 
geographic location, physician specialty, type of practice, and finance plan (prepaid 
or fee-for-service). However, Goldzweig, Mittman, Carter, Klabunde, Warren, and 
Ballard-Barbash (1997) found significantly different in rates of cataract extraction in 
FFS and prepaid settings. Their study included 43387 staff-model HMO enrollees, 
19050 IPA enrollees, and 47 150 FFS beneficiaries (a 5% sample of all Southern 
California FFS beneficiaries) aged 65 years and older. After controlling for age, sex, 
and diabetes mellitus status, they found that FFS beneficiaries were twice as likely to 
undergo cataract extraction as were prepaid beneficiaries. Yet, such investigations 
must assess the appropriateness of cataract surgery by evaluating its use relative to 
clinical need to determine whether there is overuse in FFS vs. underuse in prepaid 
settings. 
Weller Coughlin, Shaffer, Krop, Shatin, and Anderson (1999) compared the 
use of health care services (physician, hospital, laboratory tests and procedures) by 
diabetic Medicare beneficiaries over the age of 65 enrolled in fee-for-service with 
those enrolled in managed care.  Fee-for-service data were drawn from 1995-1996 
claims data from the Health Care Financing Administration's Standard Analytic Files, 
while managed care data for comparable geographic areas and years were drawn 
from claims data from United Health Group. The use of health services examined 
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included physician visits, inpatient hospital admissions, emergency room visits, and 
three diabetic specific laboratory tests and procedures (urinalysis, lipids, and 
hemoglobin A1C). Preliminary findings suggested that, overall, utilization patterns are 
similar for aged Medicare beneficiaries with diabetes enrolled in fee-for-service 
compared with those enrolled in managed care. No differences existed between the 
two systems of care in the proportions of the study populations with at least one 
hospital admission during the study period or in the percent distribution of the number 
of hospital admissions. Similar results were found for diabetes specific laboratory 
tests and procedures. The only main significant finding was a larger proportion of the 
study population who were enrolled in managed care had at least one physician visit 
during the study period compared with those enrolled in fee-for-service.  
More recently, Brown, Jiang, and Fong (2005) compared rates of need for eye 
care among Medicare beneficiaries with network-model Medicare + Choice (MC) and 
fee-for-service (FFS) health insurance.  311 MC and 107 FFS respondents with 
diabetes who are older than 65 years of age in Los Angeles County between June 
1998 and February 2000 were selected. Weighted logistic regression models were 
constructed to examine the main effect of type of insurance on the need for eye care 
within the 6 months after the examination while controlling for individual socio-
demographic and clinical characteristics, such as age, sex, race/ethnicity, education, 
and income, Medicaid and other supplemental insurance coverage, duration of 
diabetes, medical co-morbidity, and health status. In terms of care utilization, results 
showed that in the 12 months preceding the interview, the MC participants were 
significantly less likely to have seen an endocrinologist, but rates of visits to an eye 
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care provider were high and comparable in the two groups. In both groups, over 99% 
had seen a primary care provider during the same time interval. With regard to health 
outcomes, the MC participants were less likely to report hyperlipidemia and had 
significantly lower PCS (Physical Component Summary) -12 scores, but the two 
groups did not differ in duration with diabetes or number of chronic medical 
conditions.  
As for the diabetes care indicators, the study examination revealed no 
differences in blood pressure control, proteinuria, or mean hemoglobin A1C or serum 
creatinine levels.  Relative to untreated age-related eye diseases, MC participants 
had significantly higher rates of cataract, but the higher rates of diabetic retinopathy 
and glaucoma or suspected glaucoma in MC did not reach statistical significance. 
There were no significant differences between the FFS and MC participants in self-
reported eye disease or prior eye treatment. In the fully adjusted model, which 
controlled for clinical and sociodemographic characteristics and visits to an 
endocrinologist, ophthalmologist, or optometrist, 42% of MC participants compared 
with 24% of FFS participants needed further treatment or follow-up within 6 months, 
which means the higher level of need for care within 6 months for MC participants 
than for FFS participants.  
Although these studies fill the gap about evaluating quality of care effect of 
managed care on subgroup of diabetes, and provided empirical results, the 
limitations were obvious. At least, there are three reasons that deserve to be 
addressed.   
Firstly, most of the above mentioned studies focused on the comparison 
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between managed care and FFS plans, or HMO and non-HMO plans.  For example, 
Retchin et al. (1991) and Ware et al. (1996) only focused on HMOs, Coffey et al. 
(1995) on Medcaid managed care, Weller et al. (1999) on Medicare managed care, 
while Lee et al. (1998) looked at prepaid plan, and Brown et al. (2005) concentrated 
on network Medicare + Choice. Even though Greenfield et.al (1995) included HMOs 
and IPAs, they excluded other managed care plans, such as PPO plans. Managed 
care has three basic types: HMO, PPO, and POS. There are similarities between 
these different types of managed care plans but there are important differences 
between them as well. Therefore, focusing only on HMOs or treated all managed 
care together would be risky. As Riley et al. (1999) cautioned, aggregate 
comparisons of the experiences of managed care plans and FFS enrollees may 
obscure important patterns within the managed care and FFS populations. Therefore, 
it may be necessary to separate HMOs, PPOs and POSs when compared to 
traditional FFS plans if possible.  
Secondly, most of the studies examined the effect of managed care only on 
some aspects of care. Retchin et al. (1991) focused on preventive diabetes care, 
such as peripheral vascular examinations, blood pressure checks, annual renal 
function evaluations, and electrocardiograms within 6 months, etc. Greenfield et al. 
(1995) only contrasted mean health outcomes indicators, such as mean glycosylated 
hemoglobin level, mean scores for vibration sense, visual acuity, albumin excretion 
rate, blood pressure, functional status and well-being in 2-year or in 4-year outcomes, 
and average yearly mortality rates.  
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Ware et al. (1996) also compared health outcomes such as physical and 
mental health outcomes for chronically ill patients. Coffey et al. (1995) investigated 
on access to preventive diabetes care, such as physician referrals to another 
practitioner for help with weight loss if they were overweight, diet counseling, or a 
smoking cessation program, or referrals for counseling regarding diet and lifestyle. 
Weller et al. (1999) contrasted health care use, including physician visits, inpatient 
hospital admission, emergency room visits, and three diabetic specific laboratory 
tests and procedures.  Lee et al. (1998) only examined on use of ophthalmic services 
in the preceding 6 months.  
Brown et al. (2005) covered some aspects of care utilization such as 
endocrinologist visits and eye care provider visits; some aspects of health outcomes 
or complications such as PCS-12 scores and duration with diabetes or number of 
chronic medical conditions; and some aspects of preventive care such as blood 
pressure control, proteinuria, or mean HA1c or serum creatinine, to make the 
comparison across health plans. However, they examined the main effect of type of 
insurance on the need for eye care within the 6 months. Focusing on some specific 
measures could give us specific results from those aspects, however, multiple 
measures, including access to care, use of health care, especially diabetes care, and 
health outcomes, of health care effects are needed to provide comprehensive 
informative results to the public and policymakers.  
Thirdly, the data used were quite limited and out of date. For example, Retchin 
et al. (1991) collected only 158 HMO enrollees and 134 FFS enrollees from National 
Medicare Competition Evaluation to make the comparison. Greenfield et al. (1995) 
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selected 259 patients of staff-model HMOs, 61 of IPA, and 212 of FFS 259 from the 
Medical Outcomes Study (MOS).  Ware et al. (1996) used 2235 chronically ill 
patients from the MOS, whereas Lee et al. (1998) only used 522 individuals with 
diabetes enrolled in the MOS. Greenfield et al. (1995) selected only 259 patients for 
staff-model HMOs, 61 for IPA, and 212 for FFS from MOS. Brown et al. (2005) 
choose patients with diabetes who are older than 65 years of age in Los Angeles 
County.  
Many studies narrowed down the study domains such as elderly diabetics, 
diabetic elderly Medicaid beneficiaries, diabetic Medicare beneficiaries, etc, which 
only represented that specific cohort. More importantly, all these data were chosen 
from specific regions, which cannot be generalized to national wide. Furthermore, 
most of the studies were conducted before 2000. Only a single paper since then, in 
2005, made a comparison across health plans on patients with diabetes. This paper, 
however, used data only limited to Los Angeles County. Therefore, updating is 
needed as newly published data became available and managed care changed 
dramatically over years.   
Therefore, this dissertation, by using most recently published national 
representative data, seeks to provide some empirical evidence about the effect of 
managed care plans on the diabetic subgroup from a multiple dimensions 
perspective on the issues of: 1) whether managed care plans can provide sufficient 
quality of care as FFS plans does; and 2) whether managed care plans can improve 
the health outcomes of diabetes patients as FFS plans does. 
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CHAPTER THREE   
EFFECTS OF MANAGED CARE: EVIDENCE ON HEALTHCARE USE 
 
3.1 Background 
Because of their cost-containment potential, managed care plans have 
experienced explosive growth over the past two decades.  Typical methods with 
which managed care plans control costs include negotiating capitated rates or 
discounted prices with providers and strictly managing the use of medical services. 
The financial incentives of such plans would intentionally or unintentionally cut back 
on healthcare services for people with costly medical conditions, such as chronic 
diseases. Thus, despite potential cost savings linked to managed care plans, the 
public is concerned that managed care may provide insufficient quantity and quality 
of care for chronically ill people.  
Consequently, numerous studies have attempted to evaluate the effect of 
managed care in terms of quantity and quality of care on subgroups with chronic 
diseases (Ni, 1998; Soumeraiv, 1999; Smith, 1999; Erickson, 2000; Lee-Feldstein, 
2002; Shields, 2002; Beatty, 2003). However, there were very few studies in the 
literature that focused on patients with diabetes. Diabetes is one of the major causes 
of premature illness and death, and is the only major disease with a death rate that is 
still rising. In 2005, approximately 7% of individuals (20.8 million people) in the United 
States had diabetes, with 14.6 million people diagnosed and 6.2 million people 
undiagnosed. This prevalence will likely accelerate substantially further owing to 
population aging and diet during the next several decades. Moreover, many 
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complications, such as hypoglycemia, ketoacidosis, or nonketotic hyperosmolar 
coma, may occur if the disease is not adequately controlled. These complications 
from diabetes also result in significant morbidity and mortality.  
Notably, however, it has been estimated that 50% to 85% of the acute and 
chronic complications of diabetes are at least treatable and to some degree, 
preventable. This means there is great potential to maintain and improve health for 
people with diabetes through providing sufficient quantity and quality of care. 
Therefore, it is of great importance and significance to evaluate the effect of 
managed care in terms of quantity and quality of health care.  
The existing literature regarding the effect of managed care on patients with 
diabetes is sparse. Retchin et.al (1991) has evaluated the quality of care in HMOs on 
the treatment of elderly diabetics. Another study by Greenfield et.al (1995) focused 
on the mean health outcomes for patients with Non-Insulin-Dependent diabetes (also 
called diabetes mellitus type II, or NIDDM) among different care systems. Coffey et al 
(1995) measured the quality of care for diabetic elderly Medicaid beneficiaries in 
terms of drug and nondrug therapy, monitoring, and access to medications. More 
recently, Arleen et.al (2005) compared rates of need for eye care among older adults 
with diabetes mellitus under Fee-for-Service and Managed Medicare systems. 
However, most of these studies were restricted to the elderly population with diabetes. 
Few studies compared quality of care from multiple aspects for patients with diabetes 
under different health plans.  
Therefore, the goal of this study is to fill the gap. By utilizing the most-recently 
published national representative data, we will examine the effects of managed care 
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for patients with diabetes on the quantity and quality of care from the multiple aspects 
of access, satisfaction, and use of health care, including specific diabetes care. 
3.2 Data Source 
Data for the analysis were obtained from the Medical Expenditure Panel 
Survey (MEPS), the most complete source of data on the cost and use of health care 
and health insurance coverage, cosponsored by the Agency for Healthcare Research 
and Quality and the National Center for Health Statistics.  The sampling frame for 
MEPS was drawn from respondents of the National Health Interview Survey 
(conducted by the National Center for Health Statistics), a nationally representative 
sample of the U.S civilian non-institutionalized population, with over-sampling of 
Hispanics and African Americans. MEPS currently has two major components: the 
Household Component (HC) and the Insurance Component (IC). The HC collected 
data from individual households’ interviews, and was supplemented by data from 
their medical providers. The IC was a separate survey of employers that provided 
data on employer-based health insurance. MEPS HC collects detailed information for 
each person in the household on the following: demographic characteristics, health 
conditions, health status, use of medical services, charges and source of payments, 
access to care, satisfaction with care, health insurance coverage, income, and 
employment. The panel design of the survey, which features 5 rounds of interviewing 
covering two full calendar years, makes it possible to determine how changes in 
respondents' health status, income, employment, eligibility for public and private 
insurance coverage, use of services, and payment for care are related. Such a wide 
range of data points allows us for a more comprehensive approach to analysis. 
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In addition, the MEPS consolidation files include “The Diabetes Care Survey”.  
This survey contained a series of questions about diabetes management, such as 
the number of times respondents reported having a hemoglobin A1c test, his/her feet 
checked for sores or irritations, and the last time the respondent reported having an 
eye exam. Respondents were also asked to report on diabetes treatments, such as 
diet, oral medications, or insulin, and complications caused by diabetes, such as 
kidney or eye problems. This specific-disease survey allows us to examine the effect 
of health plans on patients with diabetes as they require unique health care needs. 
3.3 Sample Selection 
The data for this study were pooled from 2002 to 2006 to increase the sample 
size and were weighted to correctly represent the population. Specifically, we 
combined 2002-2006 Full Year Consolidated Data Files. We used data during this 
period because data after 2006 is unavailable, whereas data before 2002 was 
collected from different questionnaires regarding access to and satisfaction with 
health care use. We initially identified adults diagnosed with diabetes, and excluded 
the elderly population, those 65 years older, because of its near-universal coverage 
by Medicare. We then only collected those with at least one source of private health 
insurance, and excluded those with government sponsored health insurance (e.g., 
Medicaid, or CHAMPUS/VA) because these programs are associated with 
entitlement or military status, which are different in nature. Moreover, we excluded 
individuals who have more than one health plan in order to discern the effect from 
different health plans. Furthermore, we only abstracted round 1 to round 3 data due 
to some important variables that were unavailable in rounds 4-5. Finally, we excluded 
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those who changed their health plans during these rounds 1-3 to eliminate the blur 
effect caused from “plan switching”.  
Thus, due to missing data on some variables, the final sample included 1001 
observations with 484 (48.35%) enrolled in HMOs, 356 (35.56%) enrolled in OMCs, 
and 161 (16.08%) enrolled in FFS plans in rounds 1-3. 
3.4 Variables Description  
Table 3.1 list the definitions and means of the variables used in the analysis. 
The independent variables included age, sex, race/ethnicity, marriage status, 
education background, family income status, employment status, perceived health 
status, perceived mental health status, functional limitations, and other commodity 
diseases such as hypertension or heart diseases, etc. The explanatory variable of 
health insurance in this study was divided into three types: HMO (Health 
Maintenance Organization, OMC (Other Managed Care), and FFS (Fee-For-Service).  
Patients with private insurance were classified as covered by an HMO if the 
policyholder identified any plan as an HMO. Patients with private insurance were 
classified as covered by an OMC plan if the person identified any plan as a 
gatekeeper plan or any plan that had a book or list of doctors. We then classified 
those with private health insurance with non-HMOs and non-OMCs as fee-for-service 
plan. To avoid the confusing effects from different health plans, those enrolled in any 
both or three of the above three types of plans would be excluded.  It should be 
noted that while the survey permitted categorization of respondents by the type of 
health plan that they were enrolled in, questions regarding access and satisfaction, 
described below, referred to providers, not health plans.  
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We divided the interested dependent variables into three categories: access, 
satisfaction, and use of health care, which especially included diabetes care. By 
doing this, we hoped to make a broader comparison from more aspects for the 
quality of care.  
Access variables  
There are ten questions concerning a patient’s access to health care: 1) 
whether the individual has a  usual source of health care (USC) provider; 2) how long 
it takes to get to USC; 3) whether USC has office hours nights/weekends; 4) how 
difficult it is get to USC; 5) how difficult it is to contact USC by phone; and 6) how 
difficult it is to contact USC after hours; 7) whether the person was unable to receive 
medical treatment or 8) receive a prescription ; 9) whether the person was delayed in 
receiving medical treatment; 10) or delayed in receiving a prescription.   
Satisfaction variables 
Eight related questions were asked concerning the patient’s confidence and 
satisfaction with the health care provider: is the provider the person or place family 
members would go to 1) for new health problems; 2) for preventive health care; 3) for 
referrals to other health professionals; 4) to resolve ongoing health problems; and 
does the USC provider generally 5) listen to the patient and seek the patient's advice 
when choosing between treatments; 6) ask about and show respect for treatments 
other doctors may give the patient; 7) ask the patient to help make decisions; 8) 
explain options to the patient.  
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Utilization of health care variables 
Health care use was divided into ambulatory care visits, emergency room 
visits, inpatient hospital stays, and diabetes care. Ambulatory care visits included 
office-based visits and hospital outpatient visits with physician and non-physician 
settings in both categories. Non-physicians included nurse practitioners, physician 
assistants, chiropractors, optometrists, physical and occupational therapists. 
Diabetes care included management, treatment, and diabetes-related complications. 
Diabetes management included offering the HA1c test, checking the patient’s feet for 
sores or irritation, and eye examination with pupil dilation. Treatment included diet 
modification, oral medication, and insulin injections. Diabetes-related complications 
mainly included kidney problems and eye problems caused by diabetes. 
3.5 Statistical Analyses 
We used bivariate and multivariate methods and conducted the analysis with 
Stata 8 and SAS 9.0. All data were weighted to correctly represent the population. 
Chi-square (χ2) tests were used to compare individual characteristics differences 
among HMO, OMC and FFS settings. Logistic regression was used to examine 
differences in access to, satisfaction with, and use of health care across the three 
insurance groups.  Multivariate analysis was used to account for potentially 
confounding variables, including age, sex, race/ethnicity, employment, health status, 
limitation of activity status, etc. However, because the health care utilization 
measures are count variables, which are usually not normally distributed and tend to 
have a long heavy right tail, and distributions do not satisfy the assumptions for 
ordinary least squares regression, we used negative binomial regression models to 
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analyze the health care use outcomes. Incidence rate ratios (IRRs) from negative 
binomial regression models were used to compare the incidence rates of health care 
use among different health insurance groups. For example, if the IRR for ambulatory 
care visits among HMO enrollees is 1.17; the interpretation is that being an HMO 
enrollee increases the expected number of visits compared with FFS enrollees by a 
factor of 1.17, holding other variables constant. In other words, being a HMO enrollee 
increases the expected number of ambulatory care visits by 17%.  
3.6 Results 
Baseline Demographic Characteristics 
Table 3.2 presents demographic and health characteristics for patients with 
diabetes (aged 18-65) in Managed care and traditional health plans.  We find 
statistically significant differences across HMO, OMC and FFS enrollees in terms of 
ethnicity, family income, their illnesses (hypertension, heart attack,  arthritis, IADL, 
and ADL), and working status. The mean age of the sample was 52.06 (51.29 among 
HMO enrollees, 52.03 among OMC, and 54.41 among FFS enrollees). The HMO 
patients were more likely (11.88%) to be Hispanic than OMC (8.31%) and FFS 
patients (8.36%) (P=0.00). FFS enrollees had the highest proportion of hypertension 
cases (67.58%), followed by HMO (58.97%) and OMC (58.38%) (P=. 06).  
Similarly, heart attack occurred more (12.68%) among FFS enrollees 
compared to HMO (6.18%) and OMC enrollees (8.73%) (P=0.07).  FFS enrollees 
were also more likely to be diagnosed with arthritis (45.23%) compared to HMO 
(36.3%) and OMC (32.89%). The proportion of people needing help with IADL were 
the highest among FFS enrollees (4.28%, P=0.01), while ADL were highest among 
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OMC enrollees (2.35%, P=. 01). The percentage of patients working as full time was 
highest among HMO enrollees (76.94%), followed by OMC (71.01%) and FFS 
(58.67%) (P=. 00). There were no statistically significant differences between 
managed care and traditional health plan enrollees across other variables.  
Access Characteristics 
Table 3.3 presents unadjusted access characteristics (i.e. weighted but not 
controlled for other factors) of enrollees in HMO, OMC, and FFS settings. Most of the 
patients have a USC provider, with a high average over 95%. The percentage of 
patients without a USC provider was lowest in HMO plan with 3.2%, followed by 
OMC plan with 4.38%, and FFS plan with 5.89% (P=0.08).  FFS enrollees were more 
likely having no nights/weekends office hours (72.18%), compared to HMO (55.21%) 
and OMC (64.05%) enrollees (P=0.00). There were no other access measures 
significantly different among the three health insurance groups.  
Table 3.4 provides the adjusted odds ratios (ORs) for access measures by 
different groups. After controlled for covariates, FFS enrollees were more likely to 
have no USC provider (OR: 0.36***) compared to HMO enrollees. Moreover, the 
providers in FFS settings were more likely having no nights/weekends office hours 
(OR, 0.42***), and were more difficult to see provider (OR: 0.50*), when compared to 
HMO settings.  
Satisfaction Characteristics 
Table 3.5 and Table 3.6 summarize unadjusted and adjusted satisfaction 
measures. Although about 20% of the patients reported that providers did not 
listen/seek to the patient and his or her advice, most of patients (over 97%) have the 
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confidence in their service provider for new health problems, preventive health care, 
referrals to other health professionals, and ongoing health problems.  More 
reassuringly, there were no significantly differences across the plans both in 
unadjusted and adjusted satisfaction measures.  
Utilization Characteristics 
Table 3.7 provides unadjusted utilization measures across the three health 
insurance groups. About 94% of patients have at least one office-based care visit(s), 
while less than 50% of patients have at least one outpatient visit(s). FFS plans have 
a significant higher rate of at least one outpatient visit(s) (45.06%) as compared to 
the other two groups (HMO, 33.07%; OMC, 36.8%, P=0.01). In addition, FFS 
enrollees more often have at least one discharge(s) (17.59%) compared to HMO 
enrollees (13.2%) and OMC enrollees (11.26%) (P=0.06). However, patients with at 
least one night(s) in hospital for discharges has a highest proportion in OMC network 
(25.21%), and has a lowest proportion in HMO network (11.13 (P=0.04). There were 
no other differences across the health insurance groups.  
However, the adjusted incidence ratio presented on table 3.8 suggested no 
significant difference across the three plans for the measures of ambulatory care 
visits, inpatient visits, and emergency visits.  
Diabetes Care Characteristics 
Most patients (above 90%) have at least one HA1C test every year. However, 
only two thirds of patients have at least one feet-checked for sores. Less than 10% of 
patients have kidney problem caused by diabetes, and about 20% of patients has 
eye problems caused by diabetes. About 75% of patients take oral medication, while 
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about 24% of patients take insulin injection. Meanwhile, about 82% of patients follow 
diet modification as treatment. Most of the unadjusted diabetes care measures 
provide no difference across the three plans, as we can see from the table 3.9. The 
only significant difference is that, the proportion of patients with eye problems caused 
by diabetes was highest among FFS plan (24.13%), followed by OMC (18.73%) and 
HMO (16.88%) with a p-value of 0.02.  
After controlling for confounding variables, patients treated with diet 
modification have a significantly higher proportion in HMO plan compared to FFS 
plan (OR, 1.66*).  In addition, HMO enrollees were less likely to have eye problems 
caused by diabetes (OR, 0.63*). No other measures were significantly different 
across the three plans (see Table 3.10).  
3.7 Discussion and Conclusions  
Using a nationally representative sample to examine variation across different 
health plans in access to, satisfaction with, and use of health care for patients with 
diabetes, we found that most of patients with diabetes in the United States enjoyed 
good access to health care and that they were generally satisfied with the health care 
system during the years of 2002-2006. For example, we found that over 94 percent of 
insured patients had a usual source of care and over 97 percent of patients have 
confidence in their providers for their new health problems, preventive health care, 
referrals to other health professionals, and ongoing health problems. Moreover, over 
94 percent of patients have at least one office-based care visit and over 94 percent of 
them have at least one Hemoglobin A1c test per year.  
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Our analysis found three statistically significant differences in access to health 
care: 1) FFS enrollees were more likely having no USC provider than HMO and OMC 
enrollees; 2) The providers in FFS were more likely to have no nights/weekends 
office hours when compared to HMO enrollees; 3) And, FFS groups somehow had 
more difficulty acquiring medical treatment.  These findings were slightly different 
from conventional views that managed care may present more restrictive access to 
health care. However, they were consistent with the findings from Burns et al (2009) 
that relative to FFS Medicaid, Medicaid managed care programs are associated with 
an equal or improved likelihood of having a usual source of care (USC).  
In terms of satisfaction with the providers, the analysis found no significantly 
difference in any measures. This result may somehow reassure the public and 
policymakers at least for this cohort. As for the use of health care, number of nights in 
the hospital for discharges was significantly higher in FFS system compared to HMO 
system. The reason may due to the build-in cost constraint of HMO system as it uses 
capitation payments and referral strategy to restrict the health care. There is no such 
significant difference exists for OMC enrollees. Another explanation may be because 
HMO enrollees were healthier so that they had less hospital stays or were discharged 
earlier (we will test this selection bias in the next chapter). This result was slight 
different from the finding by Weller et al (1999) as they concluded that no differences 
between the two systems of care in the proportions of diabetic Medicare beneficiaries 
with at least one hospital admission, and a larger proportion of the study population 
who were enrolled in managed care had at least one physician visit during the study 
period compared with those enrolled in fee-for-service (96% vs. 63%). The difference 
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may be due to the different sample as Weller et al restricted the population to 
Medicare beneficiaries with diabetes in two geographic areas (one in the Midwest 
and one in the Northeast) because the organization of physician practices and 
managed care contracting are different in different areas (Carol, 1997). Or it may be 
due to the aggregation of managed care because it was not just managed care, but 
the type of managed care, affects the use of services (Reschovsky et al 2000). In 
addition, system may have changed during these ten years.   
Two other significant findings of this study regarding to diabetes care use were: 
FFS enrollees were more likely to have eye problems, and HMO enrollees were more 
often treated with diet modification compared to FFS enrollees. Usually, patients 
were recommended with the conventional regimen utilized diet to control FPG 
(Fasting plasma glucose), unless there were hyperglycemic symptoms or 
FPG>15mmol/l (270mg/dl), in which case pharmacological agents were added. 
Therefore, the implication here may also suggest a selection bias possibility in HMO 
plans. No other measures were significantly different across the three plans.  
The absence of significant differences in most measures of access to, 
satisfaction with, and use of health care among patients with diabetes enrolled in 
HMO, OMC and FFS merits additional discussion. This could indicate that, as 
managed care has evolved to become the predominant mechanism for organizing 
and delivering care, differences in the care provided through managed care plans 
and traditional plans have largely disappeared. In fact, physicians in private practice 
typically treat patients with a variety of different types of coverage, including 
managed care and traditional plans. They may be unaware of the type of coverage a 
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patient has during the actual visit. On the other hand, as managed care kept steady 
growth and rapidly penetration, fee-for-service plans were forced to become more 
conscious to compete with managed care (Robinson, 1996; Baker, 2000). As a 
consequence, the type of care delivered may not vary significantly by type of health 
plan.  
However, this study has several limitations. First, although the survey 
permitted categorization of respondents by the type of health plan that they were 
enrolled in, questions regarding access and satisfaction, described below, referred to 
providers, not health plans. This may dilute the effects that different health insurance 
plans have on patients with diabetes, because of the providers’ lack of awareness of 
the type of plan a patient has, as previously discussed.  
Second, although we separated HMO plans, we treated all other managed 
care plans together and didn’t distinguish PPO, POS from other managed care 
because of the data constraint. However, compared to others, this study presents its 
advantages as most previous studies only focused on HMO plans or treated all 
managed care together. 
Third, although we tried to incorporate a broader range of outcome indicators 
of quality of care, our analysis was still restricted to a small set of access, 
satisfaction, and quality indicators. In addition, many of the indicators studied used 
limited response categories (e.g., very difficult, somewhat difficult, etc.) that may not 
be particularly sensitive in distinguishing differences among different health insurance 
plans.  
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Finally, some important factors such as the duration, type and severity of 
diabetes, which are critical factors for disease-severity adjustment in comparing 
differences in diabetes care and health care use, were not considered in the survey. 
However, we used self-perceived health status and co-morbidity to control for case 
mix.  
In summary, our study found three statistically significant differences in access 
to, no statistically significant differences in satisfaction with, and only two statistically 
significant differences in the use of health care among HMO, OMC and FFS systems.  
No other measures were significantly different across the three plans. The majority 
absence of significant differences in access, satisfaction, and use of health care 
among patients with diabetes enrolled in HMO, OMC, and FFS plans, suggest that 
HMO and OMC plans can provide considerably comparable and even better health 
care services as compared to FFS plans.  
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Table 3.1: Definitions and Means of Variables (Weighted) 
 ___________________________________________________________________  
Variable                                                           Definition                         Mean (Dia) 
 ___________________________________________________________________  
 
Dependent Variables   
   
   Access:       
Has no USC Provider  1 if yes, 0 otherwise 0.040741 
More than 30 minutes to get to USC 1 if yes; 0 otherwise 0.101187 
Provider has no nights/weekends 
office hours 1 if yes; 0 otherwise 0.612258 
Somewhat or very difficult to see 
provider 1 if yes, 0 otherwise 0.055459 
Somewhat or very difficult to contact 
provider by phone 1 if yes, 0 otherwise 0.19067 
Somewhat or very difficult to see 
provider after hours 1 if yes, 0 otherwise 0.326428 
Unable to receive medical treatment 1 if yes, 0 otherwise 0.033439 
Unable to receive medicine treatment 1 if yes, 0 otherwise 0.041187 
Delayed in receiving medical 
treatment 1 if yes, 0 otherwise       0.049442 
Delayed in receiving medicine 
treatment 1 if yes, 0 otherwise 0.060828 
                                                                                               
   Satisfaction:   
Would not go for new health problems 1 if yes, 0 otherwise    0.010906 
Would not go for preventive health 
care 1 if yes, 0 otherwise 0.014003 
Would not go for referrals to other 
health professionals 1 if yes, 0 otherwise 0.021821 
Would not go for ongoing health 
problems 1 if yes, 0 otherwise 0.008547 
Provider not ask about other 
treatments 1 if yes, 0 otherwise  0.202114 
Not respect the patient 
1 if never/sometimes, 0 
otherwise 0.098575 
Not ask the person to help make 
decisions 
1 if never/sometimes, 0 
otherwise 0.155832 
Not explain options 1 if yes, 0 otherwise 0.049257 
             
   Utilization:       
Ambulatory care visits  0.944514 
(continue on next page)   
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Physician visits  
1 if at least 1 visit, 0 
otherwise   0.924583 
Non-physician visits  
1 if at least 1 visit, 0 
otherwise 0.542485 
Outpatient  0.363715 
Physician visits  
1 if at least 1 visit, 0 
otherwise   0.182872 
Non-physician visits            
1 if at least 1 visit, 0 
otherwise 0.263919 
# Nights in hospital for discharges                                      
1 if at least 1 visit, 0 
otherwise 0.128063 
# Hospital discharges   
1 if at least 1 visit, 0 
otherwise 0.131352 
Emergency room visits                                  
1 if at least 1 visit, 0 
otherwise  0.186599 
 
Diabetes care   
Management   
Hemoglobin A1c                           
1 if at least 1 visit, 0 
otherwise      0.936283 
Feet check                                              
1 if at least 1 visit, 0 
otherwise  0.715153 
Eye examination                                          
1 if at least 1 visit, 0 
otherwise   0.09756 
Complication   
Kidney problems                                        1 if yes, 0 otherwise 0.074747 
Eye problems                                          1 if yes, 0 otherwise 0.187259 
Treatment      
Diet modification                                    1 if yes, 0 otherwise 0.820978 
Oral medication                               1 if yes, 0 otherwise 0.756242 
Insulin                                                              1 if yes, 0 otherwise 0.240024 
  
                                                                                       
Independent Variables   
   
   Type of Health Plan   
FFS (reference category) 1 if Yes; 0 otherwise 0.15569 
HMO 1 if Yes; 0 otherwise 0.464018 
Other Managed Care Plans 
1 if enrolled in other 
plans; 0 otherwise           0.384747 
   
   Social Demographics    
Age Years of age 52.058 
(continue on next page)   
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Male 1 if Male; 0 otherwise 0.509579 
Black              1 if Black; 0 otherwise 0.03734 
Hispanic      1 if Hispanic; 0 otherwise 0.099578 
Education1   
1 if High School and 
Less; 0 otherwise 0.77397 
Education2       
1 if AA or Some College; 
0 otherwise 0.22603 
Married 1 if Married; 0 otherwise 0.721663 
Poor (family income as % of poverty 
line) 1 if Yes; 0 otherwise 0.033679 
Near Poor 1 if Yes; 0 otherwise  0.022911 
Low Income 1 if Yes; 0 otherwise  0.08542 
Middle Income 1 if Yes; 0 otherwise 0.34318 
High Income 1 if Yes; 0 otherwise 0.51481 
   
   Health Characteristics   
Overweight 
1 if overweight 
(BMI>=25)  0.88931 
Physical activity 
1 if moderate/vigorous 
physics activity per week 0.461846 
Smoking Status          1 if Yes; 0 otherwise 0.174622 
    Hypertension 1 if Yes; 0 otherwise 0.600794 
Coronary Heart Disease 1 if Yes; 0 otherwise 0.107758 
Heart Attack 1 if Yes; 0 otherwise  0.081701 
Heart Condition/disease 1 if Yes; 0 otherwise 0.090442 
Stroke 1 if Yes; 0 otherwise 0.037309 
Emphysema 1 if Yes; 0 otherwise 0.014385 
Asthma 1 if Yes; 0 otherwise 0.146605 
Angina 1 if Yes; 0 otherwise    0.065928 
Arthritis 1 if Yes, 0 otherwise 0.363914 
Joints (pain/aching) 1 if Yes; 0 otherwise 0.490076 
Perceived health status 
1 excellent; 2 very good; 
3 good; 4 fair; 5 poor  3.109677 
Mental Health index  1 if Yes; 0 otherwise                                                   2.089975 
Functional Limitation(s)  1 if Yes; 0 otherwise                                                   0.232853 
    Need Help w/ADL 1 if Yes; 0 otherwise 0.013692 
    Need Help w/IADL 1 if Yes; 0 otherwise 0.029516 
 
 ___________________________________________________________________  
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Table 3.2: Characteristics of Enrollees, by Plan Type 
 
 
 FFS HMO OMC P-value 
     
N 161 484 356  
     
Mean Age 50.68 51.3 52.12 0.7134 
     
Sex       0.6622 
Female 47.49 48.5 50.31  
Male 52.51 51.5 49.69  
     
Race      0.5556 
Non-Black 95.79 96.15 96.6  
Black 4.21 3.85 3.4  
     
Origin     <.0001 
Non-Hispanic                                                   91.64 88.12 91.69  
Hispanic                                    8.36 11.88 8.31  
     
Education    0.9399 
High School                                                       79.28 76.73 77.43  
Some College 
and + 20.72 23.27 22.57  
     
Marital Status     0.2138 
Non-Married 31.04 27.99 26.35  
Married 68.96 72.01 73.65  
     
Family Income as Percent of Poverty Line 0.0159 
Poor                                                         13.68 5.03 8.03  
Near Poor                                                 0.96 1.09 1.32  
Low Income                                                  0.27 1.2 0.82  
Middle Income 2.15 3.82 2.57  
High Income 5.4 16.1 12.83  
     
Smoke Status       0.141 
No                                                                75.3 81.77 86.39  
Yes                                                                  24.7 18.23 13.61  
(continue on next page)  
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Physical Activity    0.1735 
No                                                                49.66 52.91 56.56  
Yes                                                                  50.34 47.09 43.44  
     
Overweight    0.1061 
No                                                                17.42 10.11 9.56  
Yes                                                                  82.58 89.89 90.44  
     
Checked Blood Pressure   0.4106 
No                                                                0.56 1.46 2.48  
Yes                                                                  99.44 98.54 97.52  
              
Hypertension      0.0578 
No 32.42 41.03 41.62  
Yes 67.58 58.97 58.38  
     
Coronary Heart Disease     0.1301 
No 85.76 91.76 87.6  
Yes 14.24 8.24 12.4  
     
Heart Attack         0.0655 
No 87.32 93.82 91.27  
Yes 12.68 6.18 8.73  
     
Other Heart Disease           0.8856 
No 92.48 92.86 88.06  
Yes 7.52 7.14 11.94  
     
Stroke       0.7741 
No                           96.02 95.76 96.97  
Yes                                  3.98 4.24 3.03  
     
Angina    0.2694 
No                                                                92.25 92.85 94.55  
Yes                                                                  7.75 7.15 5.45  
     
Emphysema        0.9751 
No                                                                 98.21 98.72 98.51  
Yes                                                                 1.79 1.28 1.49  
(continue on next page) 
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Asthma       0.9711 
No                                        88.78 85.33 83.96  
Yes                                       11.22 14.67 16.04  
     
Joints (Pain/Aching)         0.4619 
No                                       46.51 51.02 52.78  
Yes                                           53.49 48.98 47.22  
     
Arthritis          0.0393 
No                                                     54.76 63.65 67.11  
Yes                               45.24 36.35 32.89  
     
Self-Reported Health Status                                                                                                        0.1334
           Excellent 10.57 7.27 5.75  
           Very Good 22.44 19.43 16.88  
           Good 32.33 37.88 43.45  
           Fair 25.98 26.75 22.92  
           Poor 8.67 8.66 11  
     
Mental Health Index     0.2813 
           Excellent 42.6 37.84 35  
           Very Good 19.76 23.42 30.45  
           Good 27.65 29.77 27.38  
           Fair 9.99 6.92 6.76  
           Poor 0 2.05 0.41  
     
Need Help W/IADL     0.0059 
           No                                           95.72 98.55 95.8  
           Yes                                          4.28 1.45 4.2  
     
Need Help W/ADL      0.007 
           No                                          98.22 99.59 97.65  
           Yes                                   1.78 0.41 2.35  
     
Functional Limitations                                                 0.3409 
            No                                              77.2 77.48 75.61  
            Yes                                           22.8 22.52 24.39  
     
Working Status        0.0018 
(continue on next page)   
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Non-Full Time                            41.33 23.06 28.99  
Full Time                                  58.67 76.94 71.01  
     
Total Amt Paid by Self/Family                                                           0.4536 
$ 0-1000                                      50.66 56.1 50.51  
$ 1001-2,000                                24.67 27.65 28.37  
$ 2,001-3,000                              11.75 7.31 9.32  
$ 3,001 and 
Above                       12.92 8.93 11.8  
     
Total Health Care Exp   0.3644 
$ 0-1000                                6.4 13.38 7.15  
$ 1001-2,000                                 22.03 14.3 11.13  
$ 2,001-3,000                           8.92 10.24 13.25  
$ 3,001 and 
Above                  62.65 62.08 68.47  
     
     
 
 
 
Notes: Table represents pooled data from MEPS in the years of 2002-2006 
with diabetes. 
* p<0.10; ** p<0.05; *** p<0.01, statistical significance for the difference of 
each specified characteristic variable among HMO, PPO, and FFS enrollees 
(Reference category: FFS) 
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Table 3.3: Unadjusted Access Characteristics of Enrollees in HMO, OMC, FFS 
                                                                                                                              
                                                                                                          Percent  
   ________________________________________ 
Access Characteristics                                                                            
 FFS HMO OMC Total  P-value 
      
Has no USC Provider  5.89 3.2 4.38 4.07406 0.0848 
More than 30 minutes to get to USC 12.19 8.77 10.91 10.11874 0.1557 
Provider has no nights/weekends 
office hours 72.18 55.21 64.05 61.22583 <.0001 
Somewhat or very difficult to see 
provider 8.13 3.15 7.4 5.54588 0.1226 
Somewhat or very difficult to contact 
provider by phone 19.21 16.31 22.33 19.06704 0.3877 
Somewhat or very difficult to see 
provider after hours 33.64 31.91 33.24 5.54588 0.9888 
Unable to receive medical treatment 2.85 2.08 5.06 3.34392 0.6168 
Unable to receive medicine 
treatment 5.36 3.24 4.67 4.11866 0.2842 
Delayed in receiving medical 
treatment 3.66 5.33 5 4.94423 0.7677 
Delayed in receiving medicine 
treatment 4.75 6.27 6.4 6.08277 0.5316 
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Table 3.4: Adjusted Access Characteristics of Enrollees in HMO, OMC, FFS 
                                                                                                            Odds Ratio  
    
__________________ 
Access Characteristics                                                                       FFS HMO OMC 
 
 
Has no USC Provider  ref   0.36** 0.5 
More than 30 minutes to get to USC ref   0.88 1.35 
Provider has no nights/weekends office hours ref   0.42 *** 0.73 
Somewhat or very difficult to see provider ref   0.50* 1.06 
Somewhat or very difficult to contact provider by phone ref   1 1.32 
Somewhat or very difficult to see provider after hours ref   1.09 1 
Unable to receive medical treatment ref   0.81 2.15 
Unable to receive medicine treatment ref      0.53 1.07 
Delayed in receiving medical treatment ref   0.82 0.64 
Delayed in receiving medicine treatment ref   0.96 1.7 
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Table 3.5: Unadjusted Satisfaction Characteristics of Enrollees in HMO, OMC, FFS 
                                                                                                                             Percent   
    
_____________________________________ 
Satisfaction Characteristics            
 FFS HMO OMC Total P-value 
      
Would not go for new health 
problems 0.69 1.39 0.89 1.0906 0.5344 
Would not go for preventive health 
care 1.39 2.32 0.3 1.4003 0.1518 
Would not go for referrals to other 
health professionals   1.13 2.53 2.19 2.1821 0.3296 
Would not go for ongoing health 
problems 0.43 0.77 1.13 0.8547 0.8706 
Provider not listen/ seek to the 
person and his advice 15.89 19.78 22.49 0.2021 0.6194 
Not respect the patient 7.81 11.68 8.48 9.8575 0.2743 
Not ask the person to help make 
decisions 12.05 18.51 13.4 15.583 0.1724 
Not explain options 1.8 5.62 5.34 4.9257 0.3075 
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Table 3.6: Adjusted Satisfaction Characteristics of Enrollees in HMO, OMC, FFS 
                                                                                                            Odds Ratio  
     
________________ 
Satisfaction Characteristics   FFS HMO OMC 
    
    
Would not go for new health problems ref 0.68 0.69 
Would not go for preventive health care ref   0.87 0.35 
Would not go for referrals to other health professionals   ref   4.27 3.07 
Would not go for ongoing health problems ref   1.63 1.69 
Provider not listen/ seek to the person and his advice ref   1.25 1.36 
Not respect the patient ref   1.17 0.79 
Not ask the person to help make decisions ref   1.48 1.09 
Not explain options ref   2.38 1.41 
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Table 3.7: Unadjusted Utilization for Enrollees in HMO, OMC, FFS 
 
                                                                                                                             Percent    
     
________________________________________ 
Utilization Characteristics            
 FFS HMO OMC Total  P-value 
(At Least One)      
       
Office-based care visit(s) 95.25 93.63 95.1 0.9445136 0.1124 
       Physician visit(s)   92.05 92.28 92.84 0.9245829 0.2492 
       Non-physician visit(s)            55.92 50.55 58 0.5424848 0.132 
Outpatient 45.06 33.07 36.8 0.3637148 0.0127 
       Physician visit(s)  19.91 16.57 19.68 0.1828717 0.1203 
       Non-physician visit(s)       31.2 25.76 32.02 0.2639193 0.2198 
Night(s) in hospital for discharges                                      12.72 11.13 25.21 0.1280628 0.0395 
Hospital discharge(s) 17.59 13.2 11.26 0.131352 0.059 
Emergency room visit(s)       18.12 20.32 16.9 0.1865985 0.8308 
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Table 3.8: Adjusted Utilization for Enrollees in HMO, OMC, FFS 
                                                                                                            IRR  
     
______________________  
Utilization Characteristics                                              FFS HMO OMC 
    
Office-based care visits ref 1.04 1.02 
       Physician visits   ref 1.01 0.95 
       Non-physician visits            ref  1.2 1.3 
Outpatient ref 0.79 0.92 
       Physician visits  ref 0.92 0.91 
       Non-physician visits            ref 0.7 0.87 
# Nights in hospital for discharges ref 0.56* 0.7 
# Hospital discharges ref 0.65 0.76 
Emergency room visits                         ref 0.85 0.79 
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Table 3.9: Diabetes Care for Enrollees in HMO, OMC, FFS 
                                                                                            Percent                                                   
                                              
___________________________________________     
Diabetes Care Characteristics                                             FFS HMO OMC Total P-value 
      
Management      
       At least one Hemoglobin A1C           93.72 91.79 95.67 0.9362834 0.3368 
       At least one feet check              66.38 74.33 70.14 0.7151526 0.2131 
       Never had eye examination 11.06 8.96 10.18 0.0975602 0.7479 
Complication      
        Kidney problems                                        6.23 7.72 7.69 0.074747 0.9822 
        Eye problems                                    24.13 16.88 18.73 0.187259 0.0202 
Treatment         
         Diet modification        80.83 84.46 79.8 0.820978 0.1845 
         Oral medication                               71.39 75.45 77.53 0.7562416 0.5098 
         Insulin                     25.66 24.5 22.74 0.240024 0.455 
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Table 3.10: Diabetes Care for Enrollees in HMO, OMC, FFS 
                                                                                                          Odds Ratio 
unless indicated  
     
____________________________  
      
Diabetes Care Characteristics                                              FFS HMO OMC  
     
Management     
       Hemoglobin A1C             ref     1   1.04 IRR 
       Feet check                                               ref    1.09   1.02 IRR 
       Never had dilated-eye examination ref      0.91   1.2  
Complication     
        Kidney problems                                         ref      1.59   1.33  
        Eye problems                                     ref      0.63*   0.72  
Treatment        
         Diet modification        ref       1.66*   1.25    
         Oral medication                                ref      0.92   1.1  
         Insulin                     ref      0.91   0.9  
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CHAPTER FOUR  EFFECTS OF MANAGED CARE:  
EVIDENCE ON HEALTH STATUS OUTCOME 
 
4.1 Background 
Health outcomes directly affect the length or quality of a people’s lives. Health 
plans, as a tool to delivery health care, play an important role to provide sufficient 
quantity and quality of care to maintain and improve the enrollees’ health outcomes. 
An extensive literature has emerged to examine the effect of health plans on the 
quantity and quality of health services provision by comparing managed care plans 
and traditional FFS plans (Miller and Luft, 1994, 1997, 2002; Soumerai, 1999; 
Potosky , 1999; Riley, 1999; Roetzheim, 2000; Lee-Feldstein, 2002; Retchin , 1991; 
Smith, 1999; Beatty, 2003). However, there were very few studies examined the 
quality of care effect of managed care plans in terms of health outcomes.  
In particular, literature about the health outcomes effects from different health 
plans for patients with diabetes have been extremely limited. By using the Medical 
Outcome Study (MOS), which restricted population size to three cities of Boston, Los 
Angeles, and Chicago, Greenfield et al (1995) compared the outcomes of patients 
with hypertension and diabetes for three different systems of care (FFSs, HMOs, 
IPAs) with follow-up at three periods: 2-year, 4-year, and 7-year. They found that, 
relative to functional status and well-being, there were no statistically significant 
differences among the three systems of care in 2-year outcomes or in 4-year 
outcome in the 317 patients.  The adjusted mortality rates were also similar among 
systems in 7-year follow up period. Using the same data source of the MOS, Ware et 
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al (1996) contrasted physical and mental health outcomes for patients with diabetes 
and other four chronic diseases under different health plans (HMOs vs FFSs) with a 
4-year (1986-1990) follow up observational study of 2235 patients. The authors 
demonstrated that physical and mental health outcomes did not differ for the general 
patient populations.  
However, for elderly patients treated under Medicare, declines in physical 
health were more common in HMOs than in FFS plans. Since these studies restricted 
samples to three cities, the results could not be generalized to general patients with 
diabetes. Moreover, since these studies were conducted 15 years ago, updating is 
needed because of their older data, as well as managed care’s persistent changing 
over years.  
This current study, therefore, attempts to explore the health outcome effect 
from different health plans for patients with diabetes. By using the most-recently 
published national representative data as in chapter 3, researchers, policymakers, 
clinicians, and the general public may benefit from objective, comparative information 
across diverse health care delivery systems on health outcome for patients with 
diabetes. 
4.2 Model Specification 
The model of health production function employed here follows Grossman’s 
(1972) theoretical model. The main idea of this model was to treat social, economic, 
and environmental factors as inputs of the health production system. The modified 
model specification is as follows:  
H i,t = β 0 + β 1 HI i,t + β 2 X i,t + β 3 HC i,t  + β 4 HB i,t + β 6 Year + ε i,t, 
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where an individual’s health in period t (Hi,t) is determined by his/her health 
plan type (HI i,t); a vector of socio-demographic variables such as age, gender, race, 
marital status, education level, and household wealth; his/her health conditions, such 
as chronic diseases and functional limitations; a vector of lifestyle behaviors, such as 
smoking and physical exercise; and the year of the survey.  
For the dependent variable, we use self-perceived health status (Hi,t) because 
this is an overall evaluation of an individual's degree of wellness or illness with 
reference to morbidity, impairments, anthropological measurements, mortality, and 
indicators of functional status and quality of life. It has five categories, with which 1 
means excellent, 2 means very good, 3 means good, 4 means fair and 5 means poor. 
As the explanatory variable of interest, health insurance plan (HI i,t ),  were 
divided into three categories: HMO, OMC (Other Managed Care), and FFS as 
defined in chapter three. We then created two dummy variables, HMO and OMC, to 
indicate the individual’s health plan type, with the reference category of FFS plan. If 
the coefficient on HMO or on OMC differs significantly from zero, it suggests that plan 
affect health outcome significantly different from FFS plan. Recall that we excluded 
individuals who have more than one health plan in order to discern the effect from 
different health plans. In addition, we abstracted only round 1 to round 3 data due to 
some important variables that were unavailable in rounds 4-5. We excluded those 
who changed their health plans during these rounds 1-3 to eliminate the blur effect 
caused from “plan switching”. 
Finally, there is one concern that the health outcome is not an “instantaneous 
effect”.  That is, only if the individual enrolled in one plan for an extended period of  
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time could we conclude that whether that plan will benefit or contribute to his/her 
health outcome or not. However, since we used those patients who were staying the 
same health plan during the 1st and 3rd rounds, which guaranteed us at least for a 
certain period of time (approximately 1 year) that they were staying at the same 
health plan. In addition, for most of the respondents, they have been in their plan for 
a while by the time they responded to the 1st round survey due to the annual open 
enrollment policies from employers for private health insurance. This, to some extent, 
could justify the health status as an outcome of the health plan.  
4.3 Model Validity 
Since the dependent variable of self-perceived health status is ordinal (with 1 
excellent, 2 very good, 3 good, 4 fair, and 5 poor), a natural approach is ordinal 
logistic models. Such models, however, assume that cumulative odds ratios are 
homogeneous across different levels of the dependent variable, i.e., the effects of 
predictors are invariant to the choice of cut-point category (proportional odds 
assumption). That is, only if this assumption holds, results produced from an ordered 
logistic model are valid (DeMaris, 1992).  
Table 4.1: Score Test for the Proportional Odds Assumption 
___________________________________________________________________ 
        Chi-Square       DF     Pr > ChiSq 
         7557324.53       99         <.0001 
 
The Chi-Square Score test for the proportional odds assumption from the 
analysis rejected the null hypothesis, which means the violation of the assumption. 
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Therefore, application of ordinal logistic models to this study may yield misleading 
results. We then use a less restrictive model, i.e., general multinomial logistic 
regression models, to do the estimation. As the dependent variable of health status 
also can be treated as a categorical variable and multinomial logistic regression is an 
example of such a model, it should be sufficient to satisfy the research purpose here.  
4.4 Selection Bias 
The assumption underlying the basic OLS (Ordinary Least Square) regression 
model described in the above equation is that the right-hand-side variables are 
uncorrelated with the error term and that the error term is well-behaved (i.e., 
homoskedastic and no autocorrelation).  However, as we indicated in chapter 3, there 
may be a selection bias of health plan. That is, as many researchers have also 
suspected, healthier people may prefer to enroll in HMO or other managed care 
plans because they were more affordable.  This possibility increased as we observed 
(from table 3.2) that people enrolled in managed care plans, especially HMOs, 
seemed to have lower percentages on most of diseases such as hypertension, heart 
diseases, heart attack, etc. If this is true, a biased and inconsistent estimate would be 
produced if simple ordinary least squares estimation is used in case of selection bias. 
In other words, the ignorance of adequate control for this selection bias in different 
health plans could threaten the validity of findings regarding to the discrepancies in 
health outcomes across plans.  
To control selection bias and to get an unbiased and consistent estimation, we 
choose a set of instruments to do diagnostic tests and formal Durbin-Wu-Hausman 
tests (Davidson and MacKinnon, 1993) to test for the endogeneity (selection bias) of 
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health plan type.  We would then modify the health production estimation methods 
accordingly to account for the endogeneity of plan type if test results justify it.  
4.5 Instrumental Variables Identification and Hausman Test 
In order to test for the endogeneity of health plan type, reduced form 
equations are required to specify the demand for each type of plans. Only if there are 
adequately valid instrumental variables (IVs) for the model can we get reliable 
estimation of the health production functions. Instrumental variables are variables 
that are correlated with the endogenous variables, but not correlated with the error 
term of the structural equation in the production function. In general, adequacy and 
validity of instruments should be diagnostically tested (through F-statistic and Sargan 
test) before the endogeneity test, because if the diagnostic test fails, in particular the 
Sargan test, then the endogeneity test is invalid, since the model is not properly 
identified (Larcker and Rusticus,  2010).  
We first identified instrumental variable candidates based on theory and prior 
literature. As theory predicts, many studies of health plan choice have found price 
having a negative and significant effect on the probability of enrolling in a health plan 
(Scanlon, 1997). Deductible, co-insurance, or copay amount were also among the 
primary variables that may affect the choice of health plan type. Expected out-of-
pocket costs, however, is a more integrated consideration that associated with health 
plan choice (Schoenbaum, Spranca, Elliott, Bhattacharya, 2001). Since expected 
out-of-pocket costs were only known to the consumers and unprocurable, we used 
actual out-of-pocket costs instead. Other variables such as health plan choice 
(Hellinger, 2000), and individuals’ attitudes toward health insurance were also 
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considered as our initial set of instrumental variables candidates. Thus, we consider 
four groups of instrumental variable candidates: 
• Out of pocket costs: Respondents’ self-reported total out-of-pocket 
payment for the individual or family. We divided total out-of-pocket payment into four 
categories: 1. $0-1000; 2. $1000-2000; 3, $2000-3000, 4, greater than $3000.  
• Health plan choice 
• Individuals’ attitudes towards health insurance: individuals’ assessment 
about the statements “do not need health insurance” , “health insurance is not worth 
the money it costs”, “Am more likely to take risks than the average person”, ‘Can 
overcome illness without help from a medically trained person”, on a 5-point Likert 
scale ranging from 1 = disagree strongly to 5 = agree strongly.  
Then we applied diagnostic tests to ensure the quality of instruments and to 
select acceptable instruments. The relevance property was examined by checking 
the significance level of individual instruments from the first-stage equation, the F-
statistic on the joint significance of all instruments as a whole. The validity property 
was examined by conducting a Sargan test of over-identifying restrictions.  
The detailed process of instrument selection is not reported in this dissertation. 
However, diagnostic tests results, including the tests of relevance (through F-statistic) 
and over-identifying restriction (through the Sargen test), are presented in table 4.2.  
Finally, three instrumental variables passed the validity and relevance criteria: health 
plan choice, individuals assessment about the statement “health insurance is not 
worth the money it costs”, and total out-of-pocket payment in the range of $1000-
2000.  
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Table 4.2: F-statistic Test Result and Sargen Test Result 
F-statistic:          F (3,   424) =    4.80              Prob > F =    0.0027 
Note: significant at 1% critical value, which means relevant. 
Sargan test:       NR2=472*0.0007=0.3304 ~ χ2 (2) = 5.99  
Note: insignificant at 1% critical value, which means well-identified. 
 
The relevance and validity of selected instruments justified us to continue to 
the formal Durbin-Wu-Hausman test for the endogeneity of health plan. Table 4.3 
reports the results from the formal Durbin-Wu-Hausman test for endogeneity.  The 
insignificance of health plan residual indicates no endogeneity existing, that is, we 
can just treat health plan as an exogenous predictor of the dependent variable - 
health status. 
Table 4.3: Durbin-Wu-Hausman Test Result 
 
Wu-Hausman F test:                  F (1,   451) =    0.42 
                                                   Prob > F =    0.5170 
 
Theoretically, however, this result suggests that no selection bias of health 
plan exists among patients with diabetes. That is, there is no evidence showing that 
HMOs or OMCs were more favorable than FFSs among healthier/unhealthier 
patients. This is consistent with other evidences of no selection bias existing among 
privately insured nonelderly population (Banthin, 1996; Reschovsky 1999/2000; 
Liang, 2004). Although there were some evidences of favorable selection bias in 
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Medicare HMOs (Eggers, 1982; Cox, 1997; Greenwald, 1998), the absence of 
selection bias seemed reasonable in this study since there were about 50% of 
enrollees didn’t have a choice of health insurance. Choice of health plans is one 
condition must to be met for selection bias to exist (Hellinger, 2000).  In addition, 
there is no significantly difference among the adjusted percentages of self-perceived 
health status across the three types of health plans (Table 3.2).  
4.6 Results 
Table 4.4 compares  the mean changes of several health outcome measures 
across the three types of health plans from round 1 to round 3 (approximately 1 year).  
These health outcome measures included self-perceived health status, perceived 
mental health status, functional limitations, ADL, and IADL. Surprisingly, for OMC 
enrollees, all means (except for perceived mental health status) declined (recalling 
that higher scores indicate worse health), which means better health during this 
period. However, for FFS enrollees, the opposite is true: all means increased, which 
indicates worse health.  HMO enrollees, however, exhibited no clear pattern: 
perceived mental health status, ADL, and IADL showed worse health outcome, while 
perceived health status and functional limitations reported better in health.  
Table 4.5 displays self-perceived health status and mental status change in 
numbers and percentages among different plans. FFS enrollees had higher 
percentage (23.60%) of getting worse in health status during round 1-3 as opposed 
to OMC (19.38%) and HMO (19.63%) enrollees. More HMO enrollees reported better 
in health status during this period. As regard to mental health, however, more HMO 
enrollees indicated better and worse compared to FFS and OMC enrollees.  
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The results from these tables only show that there were some differences in 
health outcomes under different health plans for people with diabetes. We cannot 
make any conclusion about the effect of these plans though, because there were too 
many other confounding factors (such as age, race, other health conditions, etc.) that 
may be involved. More important, if there existed a selection bias, we might give 
misleading remarks if we draw conclusion simply based on this observation. 
Therefore, we proposed a methodology as described in sections 4.2-4.5 that 
controlled for the confounding factors and selection bias. 
Since no evidence of selection bias was revealed in this study, however, type 
of health plan was treated as exogenous in the health production function. Table 4.6 
provides the results from the multinomial logistic regression for self-perceived general 
health status for patients with diabetes aged 18-65 years. When predicting health 
status, the reference category for the dependent variable is “good” health, while the 
reference category for the interested explanatory variable of health plan is “FFS”. To 
facilitate the interpretation of results, all estimated coefficients have been transformed 
into odds ratios to reflect the ratio of the probability of falling in one health outcome 
category over the probability of falling in the reference category.   
We found that: compared with similar FFS enrollees, people enrolled in HMOs 
have an odds ratio of 7.773 falling in “excellent” health category compared to “good” 
health (P=0.018). That is, HMO enrollees were more likely (7.773 times higher) fallen 
in the category of “excellent” health than “good” health, which means HMO plans 
resulted in better health outcome. Although compared to FFS enrollees, PPO 
enrollees were also more likely to fall in category of “excellent” health and HMO 
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enrollees were more likely to fall in category of “very good” health, while both types of 
enrollees were less likely to fall in categories of “fair” and “poor” health, they were not 
statistically significant.  
There were some other differences across the health plans among non-elderly 
people with diabetes.  Men were more likely (with odds ratio of 1.5822) to be in “fair” 
health than women.  Men were also shown insignificantly more likely to be in “poor” 
health and less likely to be in “excellent” health. This was consistent with the reports 
from American Diabetes Association that men with diabetes suffer more from some 
diabetes-related health problems, such as retinopathy, peripheral vascular disease, 
or amputation, than women (Diabetes Monitor, 2004). Therefore, it might be 
beneficial to bring awareness of this difference of diabetes-related health problems in 
men and women. 
 African American and Hispanics were more likely to be unhealthy than other 
people. This is not new. DHHS (U.S. Department of Health & Human Services, 2005) 
reported that the death rate and chronic diseases were more common among African 
American and Mexican American than white peers. This may due to the difference in 
genetic factors or lifestyle. Differences in access to healthcare may also play a role in 
these health disparities even though all samples here were insured. Smedley, Stith, 
and Nelson (2003) claimed that even at equivalent levels of access to care, racial 
and ethnic minorities experienced a lower quality of health services and were less 
likely to receive even routine medical procedures than white Americans. The 
government has long been aware of racial and ethnic health disparities, and has set 
the goal of eliminating disparities in diabetes health outcomes by the year 2010 
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(DHHS, 2000). However, further interventions should be taken more effectively and 
heavily to achieve this unmet challenge. 
Educational attainment too had different effects on health. Contrary to 
traditional views that education improves health by allowing people to develop 
healthy lifestyles and prosperity (Mirowsky and Ross, 2003; Karter et al., 2007), our 
finding shows that people with diabetes were significantly more likely to be in the 
category of “excellent” health for those with high school education attainment or less 
than those who have higher education. The exact reason remains unknown; however, 
one explanation may be that those with high school education attainment or less 
were more likely to do more physically demanding work rather than sedentary work 
than those who have more educational attainment.  
Physical activity, defined as spending half hour or more in moderate to 
vigorous physical activity at least three times a week, had a significant and beneficial 
impact on general health. The odds of having “fair” and “poor” health were 
insignificantly lower for exercisers than non-exercisers (0.97931 and 0.48512 
respectively).  The odds of having “very good” health for exercisers was 
insignificantly higher (1.005353), and the odds of  having “excellent” health was 
significantly higher than non-exercisers (2.479505). Therefore, it is most important to 
promote and advocate more for policies or programs about developing healthy 
lifestyle, such as choosing healthy food and physical activities, to prevent or control 
chronic diseases and improve health outcomes.   
4.7 Discussion and Conclusions 
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By using the most recently published national representative data, as was 
done in chapter 3, we examined the health outcome effect under different health 
plans for patients with privately insured nonelderly patients with diabetes.  Greenfield 
et al. (1995) found that no evidence that favored for any one system of care for 2-
year or 4-year outcomes over others for patients with NIDDM.  I find that compared to 
FFS enrollees, HMO enrollees were more likely to fall in the category of “excellent” 
health as opposed to “good” health category. Since no selection bias detected in the 
study, in some extent, this suggests HMO plans resulted in healthier outcome. 
The underlying reason may be due to HMOs’ providing relative more 
preventive health services, which prevent patients early enough from health status 
deterioration. Given the preset capitation rates, HMOs have an incentive to rely 
considerably on preventive services and chronic disease management so that 
various conditions get diagnosed and treated before complications develop. Studies 
have demonstrated that HMO enrollees are more likely than their FFS counterparts to 
be diagnosed at earlier stages of breast, colorectal, skin, and prostate cancer, all of 
which are amenable to screening (Loue, 2008). Similarly, if patients with diabetes in 
HMO plans were more likely or repeatedly to be recommended such preventive care 
as diet modification (as was the case in chapter 3) or physical exercise, they were 
more likely or easier to maintain and improve their health status.  This may in part 
explain why HMO enrollees had lower percentages in many of co-morbidities. As for 
the different conclusions with Greenfield et al. (1995), the reason may be due to their 
different samples and wider age range for the samples. Equally important, we found 
no other statistically significant difference across the three types of health plans.  
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These findings have important policy implications. As managed care plans 
trying to save money by restricting expensive health care uses, many researchers 
began to worry whether or not they could provide sufficient quality and quantity of 
health care, as well as bring forth good health outcome. This study indicates that 
overall, HMOs, as well as OMCs, could provide comparable quality of health care 
and result in comparable health status outcomes. This should reassure the public, 
providers and policymakers who have expressed concerns that managed care, 
especially HMOs, provide insufficient and poor health care to some vulnerable or frail 
subgroups.  
More importantly, our significant finding suggests that, as important as it is to 
provide sufficient quantity and quality of health care to needy and frail patients, it is 
also important to pay attention to those who were in good health status. Being 
provided with sufficient and early enough preventive care, patients in relatively good 
health could maintain and even improve their health status. If our healthcare system 
can effectively prevent new diseases from developing, the costs of future treatments 
could be avoided and substantial healthcare resources could be saved. Early 
detection and treatment of diseases before any complications progresses are of great 
importance for patients’ health, as well as for lowering health care costs.  Peters et al 
(1998) mentioned that lack of adequate preventive care will lead to an increased risk 
of the development of the acute and chronic complications of diabetes, creating an 
even greater future burden on the health care system and negative consequences for 
patients. Dawson et al (2002) also noted that the preventive management of diabetes 
should receive priority attention, and the prevention of cardiovascular disease in 
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patients with diabetes should become an imperative. Therefore, increasing effective 
preventive care today may improve health outcomes and save money for future. 
It is worth mentioning that we tried to “purge” the endogenous component of 
health plan for its selection bias. Consistent with other recent evidence (Banthin, 
2000; Reschovsky 1999/2000; Liang, 2004), however, we found no selection bias 
existing among privately insured nonelderly population. Although there was some 
evidence of favorable selection bias in Medicare HMOs (Eggers, 1982; Cox, 1997; 
Greenwald, 1998), the absence of selection bias seemed reasonable in this study 
since about 50% of enrollees did not have a choice of health insurance. Choice of 
health plans is one condition must to be met for selection bias to exist (Hellinger, 
2000).   
In addition, individuals with public coverage were excluded from the sample 
and most of the remaining persons had open enrollment once a year. Thus, they 
could not switch between plans any time they wanted to. Therefore, concerning the 
questions we issued at chapter 3, the absence of selection bias suggests that other 
explanations may apply. For example, compared to FFS enrollees, fewer hospital 
nights for HMO enrollees, and more HMO enrollees with treated with diet modification, 
may result from the build-in cost constraint strategy of HMO system as it uses 
capitation payments and referral strategy to restrict the expensive health care.  
However, the method in our study is not perfect. Without direct randomization, 
it is impossible to establish from direct observation whether HMOs experience 
selection bias, because we cannot directly observe the conduct of enrollees both in 
the setting that they chose and the setting that they did not choose (Hellinger, 2000). 
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There may still other factors we could not capture. For example, genetic traits and 
good childhood health induced by parental economic resources or healthy parenting 
styles that persist into adulthood, and good lifestyle such as physical exercises and 
refraining from smoking were all known to patients that made decisions on health 
plans, but not observed by the researchers and health plan providers. In addition, 
selection bias may also occur across jobs, (e.g., jobs with poor health insurance may 
attract healthier workers), types of health plans (e.g., HMOs may attract healthier 
enrollees than FFS plans), and among health plans of the same type (e.g., some 
HMOs may attract sicker enrollees and others may attract healthier enrollees) 
(Hellinger, 2000). We could not capture all of these in a model because of its 
complexity and data constraint.  
Another limitation of our study is we followed up only 1 year follow-up for 
health status outcome.  We were concerned that the health outcome differences 
might emerge larger subsequently. Follow-up periods longer than 1 year may be 
required to detect differences in outcomes for groups differing in chronic condition 
(Ware, 1996). In addition, our measure of health status was based on self-perceived 
reports that were not validated by medical records and may be subjective. Also, the 
dichotomous coding of health status was unable to capture patients’ exact evaluation 
of health status outcome. We also call for caution that our results and findings were 
only limited to non-elderly patients and could not be generalized to all patients with 
diabetes.  Results may vary as one uses different age range of the samples.  For 
example, Ware et al. (1996) found no difference between HMOs and FFSs among 
nonelderly patients with diabetes; however, they found that for elderly patients (those 
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aged 65 years and older) treated under Medicare, declines in physical health were 
more common in HMOs than in FFSs.  
To conclude, we found no selection bias among privately insured non-elderly 
patients with diabetes based on our methodology. No statistically significant 
difference among relative unhealthy patients in health status by type of health plans. 
However, compared with FFS plans, HMO plans resulted in better health outcome for 
relatively good health patients.  
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Table 4.4: Mean Changes in Health Outcomes Across the  
Three Types of Health Plans from Round 1 - 3 
 
 
  
                                                                                       Weighted Mean               Weighted Mean        Mean Changes During  
                                                                                           (Round1)                        (Round3)              Round 1-3
 Variable                                 Definition                 ____________________   _____________________ ________________________
                                                                                                     HMO          OMC          FFS            HMO          OMC          FFS   FFS HMO MC FFS HMO OMC FFS HMO OMC
    
Health Characteristics
Perceived health status 1 excellent; 2 very good; 2.997 3.101 3.166 3.092 2.934 3.030 0.095 -0.167 -0.135
                                        3 good; 4 fair; 5 poor 
Perceived Mental Health status1 excellent; 2 very good; 2.050 2.119 2.071 2.261 2.320 2.223 0.211 0.201 0.152
                  3 good; 4 fair; 5 poor 
Functional Limitation(s) 1 if Yes; 0 otherwise     0.228 0.225 0.244 0.262 0.179 0.231 0.034 -0.046 -0.012
            
Need Help w/ADL 1 if Yes; 0 otherwise        0.018 0.004 0.023 0.026 0.015 0.018 0.008 0.011 -0.006
Need Help w/IADL 1 if Yes; 0 otherwise                     0.043 0.015 0.042 0.057 0.031 0.027 0.014 0.016 -0.015
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Table 4.5: Number and Percentages Changes in Health Outcomes 
Across the Three Types of Health Plans from Round 1 - 3 
 
Health status changes : In number   In percentage: % 
  the same  better worse         
Total 501 298 202   50.05 29.77 20.18 
FFS 85 38 38   52.80 23.60 23.60 
HMO 225 164 95   46.49 33.88 19.63 
OMC 191 96 69   53.65 26.97 19.38 
                
Mental health changes: In number   In percentage: % 
  the same  better worse         
Total 463 319 219   46.25 31.87 21.88 
FFS 82 49 30   50.93 30.43 18.63 
HMO 205 160 119   42.36 33.06 24.59 
OMC 176 110 70   49.44 30.90 19.66 
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Table 4.6: Multinomial Logistic Regression Results Reported in Odds Ratios. 
(Dependent Variable= Self-reported General Health Status) 
Variable                    Excellent 
Very 
Good Fair  Poor 
                              
HMO 7.7734** 1.5335 0.8999 0.6453 
PPO 2.9999 0.9266 0.9194 0.8365 
Social Demographics  
Age 1.0388 1.0102 0.9861 0.9517** 
Male 0.5279 1.1022 1.5822** 1.2802 
Black 1.0694 0.2682* 1.3184 1.0506 
Hispanic 0.4263 0.7429 1.7248* 1.3077 
Education1 4.4925 0.6718 0.7982 0.4471 
Married 0.5285 0.7091 1.2001 0.9828 
Income1  2.9964 0.7572 0.6269 0.7578 
Income2   0.0000 1.4350 1.3730 1.0259 
Income3   3.2044 0.9044 1.4507 1.1600 
Invome4 0.3964 0.7282 1.2423 1.5423 
Total health expenditure 
(0-1000$) 0.3531 0.6491 0.4104 1.2428 
Total health 
expenditure(1000-2000$) 0.4327 1.2042 0.4589 2.4638 
Total health 
expenditure(2000-3000$) 0.0763 0.8565 0.6548 1.1134 
Personal lifestyle 
Behavior 
Smoke  1.5122 1.4008 1.4423 2.1222 
Physical Activity 2.4795* 1.0054 0.9793 0.4851 
Health Characteristics 
Overweight 0.3248 0.4157*** 0.4168** 0.6898 
Hypertension 0.2037*** 0.6382** 1.0514 1.4349 
Coronary Heart Disease 0.8399 0.6906 1.1873 2.2783 
Heart Attack 16.3217** 1.0495 2.5774 2.0257 
Heart Condition/disease 0.8721 2.4339 1.7683** 1.6175 
Stroke 0.0000 0.9695 0.4984 0.1093** 
Emphysema 0.0000 2.6526 0.4616 0.4884 
Angina 0.4942 1.0822 0.4434 0.9589 
(Continue on next page) 
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Asthma                                 0.3425 1.0613 0.7363 1.1205 
Arthritis 1.4719 1.3874 1.0140 1.4373 
Joints (pain/aching) 0.3761* 1.1172 1.1698 1.9829 
Need Help w/ADL 0.0000 1.5209 1.1391 5.2180 
Need Help w/IADL 0.0000 9.4748 7.6305 7.9100 
Functional Limitations 0.0000 0.5604 2.7866*** 2.5940** 
 
 
 Notes: The reference category of the dependent variable is “good” health 
status. 
* p<0.10; ** p<0.05; and *** p<0.01, statistical significance. 
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CHAPTER 5 
SUMMARIES, IMPLICATIONS, AND RECOMMENDATIONS 
 
5.1 Summaries  
This study has used up-to-date data from MEPS, a nationally representative 
survey, to examine the effect of managed care plans (as compared with traditional 
fee-for-service plans, or FFS) on the health care use and health outcome of patients 
with diabetes. It bears significance at the time that anger and frustration with 
managed care continue to grow and people become more concerned about the 
quality of health care provided to patients with high-risk disease(s).  With the increase 
in diabetes in the U.S., and the growing reliance on managed care plans, 
understanding the effects of different plans on health care utilization and health 
status is important to consumers, employers, and policymakers. In particular this 
study:  
(1) Focuses on patients with diabetes, as they make up about 8% (24 million) 
of the population, a rate that will escalate dramatically for the foreseeable future;  
(2) Separates HMOs from other managed care forms to compare with 
traditional FFSs as HMOs and other managed care plans delivery the payment in 
different ways;  
(3) Evaluates the effect of managed care from multiple dimensions so as to 
provide more comprehensive results;  
(4) Uses up-to-date and national representative data from the most complete 
source - Medical Expenditure Panel Survey (MEPS).  
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In addition, this study controls for the self-selected nature of persons in 
different health plans. One of the problems plaguing much of the research in this 
area is the possibility of systematic selection bias into managed care plans. Not 
controlling adequately for this selection bias in different health plans could threaten 
the validity of findings regarding to the discrepancies in health outcomes across plans. 
This study, therefore, has its methodological advantage in providing valid results and 
its policy implications.  
The main empirical findings in this study provide favorable evidence for the 
performance of managed care plans. Most of the measures used to evaluate the 
quality of health care of managed care plans exhibited comparable or even better 
levels than traditional FFS plans. Specifically, in terms of access to care: 1) HMO 
enrollees were more likely having USC provider than FFS enrollees; 2) The providers 
in HMOs were more likely to have nights/weekends office hours when compared to 
FFS enrollees; 3) and, managed care groups made it easier to see providers.  OMC 
plans exhibited no significant difference from FFS plans in any access measures. 
With regard to satisfaction with the providers, the analysis found no significant 
difference in any measures across the three types of plans.  
As for the use of health care, number of nights in the hospital for discharges 
was significantly lower in HMO system compared to FFS system. HMO enrollees 
were more often treated with diet modification compared to FFS enrollees.  In 
regards to health outcome, HMO enrollees were more likely fallen in category of 
“excellent” health as opposed to “good” health category when compared to FFS 
enrollees, which means use of HMO plans related to even healthier outcomes for 
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patients. OMC plans have no significant difference from FFS plans in the use of 
healthcare and health outcome. Therefore, to some extent, managed care plans 
came to mature, they could provide comparable or even better quality of care when 
compared with traditional FFS plans.   
5.2 Implications 
The empirical findings presented here carry important implications for the 
current health care system. On the one hand, the results of comparable quality of 
care from managed care plans among non-elderly patients with diabetes should 
reassure customers, policymakers, and insurers. Some recent research showed that 
managed care provided less quality of care for the elderly or those with high-risk 
diseases (Miller and Luft, 2002; Experton et al., 1999; Smith et al., 1999). People 
from different sides began to suspect that managed care may skimp on care services, 
especially specialty care, in exchange for lower costs. The perception does not hold 
here in this study, at least not for the services we examined. Managed care plans 
should be looked at more objectively.  
On the other hand, HMO enrollees were more likely fell in the category of 
“excellent” health as opposed to “good” health category when compared to FFS 
enrollees, which means HMO plans resulted in even healthier outcome for relative 
good health patients. Generally, HMO plans charge lower copays than OMC plans, 
and have no deductible or less deductible than traditional FFS plans, so enrollees 
may more easily obtain primary and preventive care. Better use of primary and 
preventive care may contribute to this success of HMOs among relatively healthy 
patients. The Patient Protection and Affordable Care Act (PPACA) signed into law 
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this March by President Barack Obama includes that “effective by 2018, all existing 
health insurance plans must cover approved preventive care and checkups without 
co-payment”. This may serve to provide more primary and preventive care 
opportunities to enrollees and thus eliminate the discrepancy across plans.   
Another implication of the study is that even though both managed care and 
traditional FFS plans provided relatively good health care services to non-elderly 
patients with diabetes, almost 20% of patients deteriorated in health within one year. 
Although age may play a role, lack of a systematic way to achieve better outcomes 
may be another important reason. Therefore, future plans, both managed care and 
traditional FFS plans, may consider to provide diabetes management (DM) program 
to patients with diabetes.  
By definition, a DM program is an “integrated system of interventions, 
measurements, and refinements of health care delivery designed to optimize clinical 
and economic outcomes within a specific (diabetic in this study) population” (Gurnee 
1997). Several studies (Aubert 1998; Peters 1998) have demonstrated the value of 
DM efforts. Rubin et al (1998) also showed that patients in the program were more 
likely to get HbA1c tests, foot exams, eye exams and lipid measurements. Meanwhile, 
the program achieved gross economic adjusted savings of $50 per diabetic member 
per month (12.3 percent). Admissions per 1,000 diabetic member years decreased 
by 18 percent and bed days fell by 21 percent.  
However, for health plans, it should be noted that benefits such as these often 
require a long-term commitment to a DM protocol. Because the savings in treatment 
costs are often years into the future, diabetes DM programs can cost more than they 
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may save in the short term (Marcille, 2000). It is true that these programs require 
front-end funds, which can be difficult to sustain, and necessitate continued support. 
It might be worthwhile in the long run, however, not only for patients’ health, but also 
for future medical expenses.  
This recommendation echoes “standards of medical care in diabetes -2010” 
set by the American Diabetes Association (ADA).  It recommended that “People with 
diabetes should receive medical care from a physician-coordinated team…… A 
variety of strategies and techniques should be used to provide adequate education 
and development of problem-solving skills in the various aspects of diabetes 
management” (ADA, 2010). Recently, news (Renée, 2010) reported that Walgreens’ 
Diabetes Management Program sparked interest of health plans, and several health 
plans and employers were considering offering it to enrollees. Therefore, future plans 
are recommended to provide a systematic way, such as DM program, to achieve 
better health outcomes for diabetic subgroup.  
5.3 Recommendations 
This study has taken a significant step toward answering an important 
research question: compared to traditional FFS plans, did managed care provide 
comparable health care services and resulted in the same health outcome among 
nonelderly patients with diabetes? However, several other aspects deserve future 
research to help clarify this issue further.  
First, follow-up periods longer than one year may better detect differences in 
health outcomes. We followed up only one year for health status outcome.  The 
health outcome differences might emerge over longer periods of time.  
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Second, further exploration of specialty care use among nonelderly patients 
with diabetes may provide more comprehensive results.  Although this study covered 
a wide range of measures of health status and care utilization, we do miss some 
other specialty care use, such as blood glucose control, urine protein or creatinine 
determination, or other diabetes management, due to data unavailability. This may be 
an important measure to examine across plans and certainly deserves further 
investigation. 
Finally, it would be also worthwhile to take a look at other subgroups with 
diabetes, such as those in Medicaid or Medicare.  There could be differences in the 
way that managed care affects those patients.  Trying to take an objective look with 
all-around perspective may help to identify the strengths and the weaknesses of the 
entire system.  
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This dissertation attempts to examine the quality effect of managed care plans 
(as compared with traditional fee-for-service plans, or FFS) on the health outcome 
and health care use of patients with diabetes. As the number of diabetics is growing 
rapidly with many of them are relying on managed care plans, knowing better the 
effects of different plans on health status and health care utilization is of great 
interest and significance to consumers, employers, and policymakers, especially at a 
time that universal health care is under being implemented. 
Using up-to-date data from MEPS, a nationally representative survey, I 
compared 484 HMO patients, 356 OMC patients, with 161 patients (who presented 
with diabetes) in terms of access to, satisfaction with, utilization of care (including 
diabetes care), and health status, to evaluate the quality of health care enrollees 
receive and their health outcome. 
95 
 
The main empirical findings in this study provide favorable evidence for the 
performance of managed care. Most of the measures we used to evaluate the quality 
of health care of managed care plans exhibited comparable level or even better to 
traditional FFS plans. Specifically, in terms of access to care,: 1) HMO enrollees were 
more likely having USC provider than FFS enrollees; 2) The providers in HMOs  were 
more likely to have nights/weekends office hours when compared to FFS enrollees; 3) 
And, HMO enrollees were much easier to see providers.  With regard to satisfaction 
with the providers, the analysis found no significant differences in any measures 
across the three types of plans. As for use of health care, HMO enrollees have lower 
number of nights in hospital for discharges and were more often treated with diet 
modification compared to FFS enrollees. In regards to health outcome, HMO 
enrollees were more likely fallen in category of “excellent” health when compared to 
FFS enrollees.  OMC plans exhibited no difference from FFS plans. 
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